Nuclear	O
localization	O
and	O
formation	O
of	O
beta-catenin-lymphoid	B-protein
enhancer	I-protein
factor	I-protein
1	I-protein
complexes	I-protein
are	O
not	O
sufficient	O
for	O
activation	O
of	O
gene	O
expression	O
.	O

In	O
response	O
to	O
activation	O
of	O
the	O
Wnt	O
signaling	O
pathway	O
,	O
beta-catenin	B-protein
accumulates	O
in	O
the	O
nucleus	O
,	O
where	O
it	O
cooperates	O
with	O
LEF/TCF	B-protein
(	O
for	O
lymphoid	B-protein
enhancer	I-protein
factor	I-protein
and	I-protein
T-cell	I-protein
factor	I-protein
)	O
transcription	B-protein
factors	I-protein
to	O
activate	O
gene	O
expression	O
.	O

The	O
mechanisms	O
by	O
which	O
beta-catenin	B-protein
undergoes	O
this	O
shift	O
in	O
location	O
and	O
participates	O
in	O
activation	O
of	O
gene	O
transcription	O
are	O
unknown	O
.	O

We	O
demonstrate	O
here	O
that	O
beta-catenin	B-protein
can	O
be	O
imported	O
into	O
the	O
nucleus	O
independently	O
of	O
LEF/TCF	B-protein
binding	O
,	O
and	O
it	O
may	O
also	O
be	O
exported	O
from	O
nuclei	O
.	O

We	O
have	O
introduced	O
a	O
small	O
deletion	O
within	O
beta-catenin	B-protein
(	O
Delta19	B-DNA
)	O
that	O
disrupts	O
binding	O
to	O
LEF-1	B-protein
,	O
E-cadherin	B-protein
,	O
and	O
APC	B-protein
but	O
not	O
axin	B-protein
.	O

This	O
Delta19	B-protein
beta-catenin	I-protein
mutant	I-protein
localizes	O
to	O
the	O
nucleus	O
because	O
it	O
may	O
not	O
be	O
efficiently	O
sequestered	O
in	O
the	O
cytoplasm	O
.	O

The	O
nuclear	O
localization	O
of	O
Delta19	B-DNA
definitively	O
demonstrates	O
that	O
the	O
mechanisms	O
by	O
which	O
beta-catenin	B-protein
localizes	O
in	O
the	O
nucleus	O
are	O
completely	O
independent	O
of	O
LEF/TCF	B-protein
factors	I-protein
.	O

beta-Catenin	B-protein
and	O
LEF-1	B-protein
complexes	I-protein
can	O
activate	O
reporter	O
gene	O
expression	O
in	O
a	O
transformed	B-cell_line
T-lymphocyte	I-cell_line
cell	I-cell_line
line	I-cell_line
(	O
Jurkat	B-cell_line
)	O
but	O
not	O
in	O
normal	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
,	O
even	O
though	O
both	O
factors	O
are	O
nuclear	O
.	O

Thus	O
,	O
localization	O
of	O
both	O
factors	O
to	O
the	O
nucleus	O
is	O
not	O
sufficient	O
for	O
activation	O
of	O
gene	O
expression	O
.	O

Excess	O
beta-catenin	B-protein
can	O
squelch	O
reporter	O
gene	O
activation	O
by	O
LEF-1-beta-catenin	B-protein
complexes	I-protein
but	O
not	O
activation	O
by	O
the	O
transcription	B-protein
factor	I-protein
VP16	B-protein
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
a	O
third	O
component	O
is	O
necessary	O
for	O
gene	O
activation	O
and	O
that	O
this	O
third	O
component	O
may	O
vary	O
with	O
cell	O
type	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
June	NULL
1999	NULL
,	NULL
p.	NULL
4503-4515	NULL
0270-7306/99/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

19	NULL
,	NULL
No	NULL
.	NULL

6	NULL
Copyright	NULL
©	NULL
1999	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Nuclear	NULL
Localization	NULL
and	NULL
Formation	NULL
of	NULL
B-Catenin-Lymphoid	NULL
Enhancer	NULL
Factor	NULL
1	NULL
Complexes	NULL
Are	NULL
Not	NULL
Sufficient	NULL
for	NULL
Activation	NULL
of	NULL
Gene	NULL
Expression	NULL
MARY	NULL
G.	NULL
PRIEVE	NULL
anp	NULL
MARIAN	NULL
L.	NULL
WATERMAN®*	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Irvine	NULL
,	NULL
Irvine	NULL
,	NULL
California	NULL
92697-4025	NULL
Received	NULL
16	NULL
December	NULL
1998/Returned	NULL
for	NULL
modification	NULL
18	NULL
January	NULL
1999/Accepted	NULL
15	NULL
March	NULL
1999	NULL
In	NULL
response	NULL
to	NULL
activation	NULL
of	NULL
the	NULL
Wnt	NULL
signaling	NULL
pathway	NULL
,	NULL
B-catenin	NULL
accumulates	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
cooperates	NULL
with	NULL
LEF/TCF	NULL
(	NULL
for	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
and	NULL
T-cell	NULL
factor	NULL
)	NULL
transcription	NULL
factors	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
B-catenin	NULL
undergoes	NULL
this	NULL
shift	NULL
in	NULL
location	NULL
and	NULL
participates	NULL
in	NULL
activation	NULL
of	NULL
gene	NULL
transcription	NULL
are	NULL
unknown	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
B-catenin	NULL
can	NULL
be	NULL
imported	NULL
into	NULL
the	NULL
nucleus	NULL
independently	NULL
of	NULL
LEF/TCF	NULL
binding	NULL
,	NULL
and	NULL
it	NULL
may	NULL
also	NULL
be	NULL
exported	NULL
from	NULL
nuclei	NULL
.	NULL

We	NULL
have	NULL
introduced	NULL
a	NULL
small	NULL
deletion	NULL
within	NULL
B-catenin	NULL
(	NULL
A19	NULL
)	NULL
that	NULL
disrupts	NULL
binding	NULL
to	NULL
LEF-1	NULL
,	NULL
E-cadherin	NULL
,	NULL
and	NULL
APC	NULL
but	NULL
not	NULL
axin	NULL
.	NULL

This	NULL
A19	NULL
B-catenin	NULL
mutant	NULL
localizes	NULL
to	NULL
the	NULL
nucleus	NULL
because	NULL
it	NULL
may	NULL
not	NULL
be	NULL
efficiently	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

The	NULL
nuclear	NULL
localization	NULL
of	NULL
A19	NULL
definitively	NULL
demonstrates	NULL
that	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
B-catenin	NULL
localizes	NULL
in	NULL
the	NULL
nucleus	NULL
are	NULL
completely	NULL
independent	NULL
of	NULL
LEF/TCF	NULL
factors	NULL
.	NULL

B-Catenin	NULL
and	NULL
LEF-1	NULL
complexes	NULL
can	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
a	NULL
transformed	NULL
T-lymphocyte	NULL
cell	NULL
line	NULL
(	NULL
Jurkat	NULL
)	NULL
but	NULL
not	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
,	NULL
even	NULL
though	NULL
both	NULL
factors	NULL
are	NULL
nuclear	NULL
.	NULL

Thus	NULL
,	NULL
localization	NULL
of	NULL
both	NULL
factors	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Excess	NULL
BB-catenin	NULL
can	NULL
squelch	NULL
reporter	NULL
gene	NULL
activation	NULL
by	NULL
LEF-1-fB-catenin	NULL
complexes	NULL
but	NULL
not	NULL
activation	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
VP16	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
a	NULL
third	NULL
component	NULL
is	NULL
necessary	NULL
for	NULL
gene	NULL
activation	NULL
and	NULL
that	NULL
this	NULL
third	NULL
component	NULL
may	NULL
vary	NULL
with	NULL
cell	NULL
type	NULL
.	NULL

Wit	NULL
signals	NULL
initiate	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
of	NULL
receptive	NULL
cells	NULL
when	NULL
the	NULL
secreted	NULL
ligand	NULL
Want	NULL
binds	NULL
to	NULL
frizzled	NULL
,	NULL
a	NULL
seven-transmembrane	NULL
receptor	NULL
on	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
15	NULL
,	NULL
43	NULL
)	NULL
.	NULL

For	NULL
Wat-1	NULL
,	NULL
this	NULL
binding	NULL
event	NULL
activates	NULL
a	NULL
multistep	NULL
cascade	NULL
that	NULL
directs	NULL
nuclear	NULL
transport	NULL
of	NULL
a	NULL
cytoplasmic	NULL
protein	NULL
named	NULL
B-catenin	NULL
.	NULL

Wat-1	NULL
directs	NULL
nuclear	NULL
localization	NULL
of	NULL
B-catenin	NULL
in	NULL
part	NULL
by	NULL
inhibiting	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
GSK-3f	NULL
via	NULL
the	NULL
action	NULL
of	NULL
a	NULL
cytoplasmic	NULL
phosphoprotein	NULL
named	NULL
dishevelled	NULL
(	NULL
14	NULL
,	NULL
35	NULL
,	NULL
61	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Most	NULL
models	NULL
portray	NULL
GSK-3	NULL
$	NULL
,	NULL
along	NULL
with	NULL
another	NULL
protein	NULL
called	NULL
APC	NULL
(	NULL
for	NULL
adenomatous	NULL
polyposis	NULL
coli	NULL
)	NULL
,	NULL
as	NULL
promoting	NULL
B-catenin	NULL
degradation	NULL
via	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
1	NULL
,	NULL
52	NULL
,	NULL
57	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
circum-stances	NULL
,	NULL
B-catenin	NULL
is	NULL
stable	NULL
only	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
in	NULL
cell	NULL
adherens	NULL
junctions	NULL
as	NULL
an	NULL
adapter	NULL
protein	NULL
between	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
E-cadherin	NULL
receptors	NULL
and	NULL
«	NULL
-catenin	NULL
,	NULL
a	NULL
cytoskeleton	NULL
binding	NULL
protein	NULL
.	NULL

A	NULL
Wat-dependent	NULL
increase	NULL
in	NULL
cytosolic	NULL
B-catenin	NULL
is	NULL
soon	NULL
followed	NULL
by	NULL
the	NULL
appearance	NULL
of	NULL
B-catenin	NULL
in	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
cooperates	NULL
with	NULL
LEF/TCF	NULL
(	NULL
for	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
and	NULL
T-cell	NULL
factor	NULL
)	NULL
proteins	NULL
to	NULL
alter	NULL
transcription	NULL
of	NULL
gene	NULL
targets	NULL
(	NULL
29	NULL
,	NULL
44	NULL
,	NULL
49	NULL
,	NULL
53	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
parts	NULL
of	NULL
the	NULL
cascade	NULL
,	NULL
additional	NULL
steps	NULL
are	NULL
involved	NULL
because	NULL
proteins	NULL
such	NULL
as	NULL
axin/conductin/axil	NULL
and	NULL
GBP	NULL
have	NULL
been	NULL
identified	NULL
recently	NULL
as	NULL
regulatory	NULL
components	NULL
of	NULL
this	NULL
pathway	NULL
(	NULL
6	NULL
,	NULL
32	NULL
,	NULL
34	NULL
,	NULL
69	NULL
,	NULL
70	NULL
,	NULL
72	NULL
)	NULL
.	NULL

The	NULL
final	NULL
steps	NULL
of	NULL
this	NULL
cascade	NULL
,	NULL
nuclear	NULL
accumulation	NULL
and	NULL
gene	NULL
activation	NULL
by	NULL
B-catenin	NULL
,	NULL
are	NULL
not	NULL
well	NULL
characterized	NULL
.	NULL

B-Catenin	NULL
is	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
,	NULL
and	NULL
the	NULL
list	NULL
of	NULL
these	NULL
interactions	NULL
is	NULL
growing	NULL
(	NULL
conductin/axin/	NULL
axil	NULL
,	NULL
APC	NULL
,	NULL
«	NULL
-catenin	NULL
,	NULL
E-cadherin	NULL
,	NULL
presenilin	NULL
,	NULL
LEF/TCF	NULL
pro-teins	NULL
)	NULL
(	NULL
10	NULL
,	NULL
71	NULL
)	NULL
.	NULL

These	NULL
proteins	NULL
are	NULL
localized	NULL
to	NULL
different	NULL
subcellular	NULL
compartments	NULL
,	NULL
such	NULL
as	NULL
the	NULL
plasma	NULL
membrane	NULL
(	NULL
E-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
19182	NULL
Jamboree	NULL
Blvd	NULL
.	NULL

,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
Irvine	NULL
,	NULL
Irvine	NULL
,	NULL
CA	NULL
92697-4025	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
949	NULL
)	NULL
824-2885	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
949	NULL
)	NULL
824-8598	NULL
.	NULL

E-mail	NULL
:	NULL
mlwaterm	NULL
@	NULL
uci.edu	NULL
.	NULL

4503	NULL
cadherin	NULL
,	NULL
-catenin	NULL
)	NULL
,	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
and	NULL
Golgi	NULL
(	NULL
presenilin	NULL
and	NULL
derivative	NULL
fragments	NULL
)	NULL
,	NULL
the	NULL
cytoplasm	NULL
(	NULL
APC	NULL
,	NULL
conductin/axin/axil	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nucleus	NULL
(	NULL
LEF/TCF	NULL
transcription	NULL
factors	NULL
)	NULL
.	NULL

Although	NULL
interaction	NULL
domains	NULL
for	NULL
each	NULL
individual	NULL
protein	NULL
have	NULL
not	NULL
been	NULL
precisely	NULL
delimited	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
B-catenin	NULL
interacts	NULL
with	NULL
these	NULL
proteins	NULL
through	NULL
overlapping	NULL
portions	NULL
of	NULL
its	NULL
armadillo	NULL
repeat	NULL
array	NULL
(	NULL
reference	NULL
10	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

The	NULL
repeating	NULL
unit	NULL
of	NULL
this	NULL
array	NULL
,	NULL
the	NULL
armadillo	NULL
repeat	NULL
(	NULL
referred	NULL
to	NULL
here	NULL
as	NULL
the	NULL
arm	NULL
repeat	NULL
)	NULL
is	NULL
so	NULL
named	NULL
because	NULL
of	NULL
its	NULL
sequence	NULL
similarity	NULL
to	NULL
a	NULL
reiterated	NULL
,	NULL
degenerate	NULL
37-	NULL
to	NULL
43-ami-no-acid	NULL
(	NULL
aa	NULL
)	NULL
motif	NULL
in	NULL
the	NULL
Drosophila	NULL
melanogaster	NULL
ortholog	NULL
armadillo	NULL
(	NULL
41	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Multiple	NULL
arm	NULL
repeats	NULL
occur	NULL
in	NULL
tandem	NULL
arrays	NULL
from	NULL
as	NULL
few	NULL
as	NULL
4	NULL
to	NULL
as	NULL
many	NULL
as	NULL
13	NULL
repeats	NULL
,	NULL
and	NULL
together	NULL
they	NULL
function	NULL
as	NULL
a	NULL
protein	NULL
interaction	NULL
domain	NULL
.	NULL

The	NULL
crystal	NULL
structure	NULL
for	NULL
the	NULL
12	NULL
arm	NULL
repeats	NULL
of	NULL
B-catenin	NULL
was	NULL
solved	NULL
recently	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Structural	NULL
analysis	NULL
has	NULL
revealed	NULL
that	NULL
arm	NULL
repeats	NULL
are	NULL
alpha-helical	NULL
and	NULL
pack	NULL
against	NULL
one	NULL
another	NULL
to	NULL
form	NULL
an	NULL
elongated	NULL
superhelix	NULL
of	NULL
alpha-helices	NULL
.	NULL

The	NULL
groove	NULL
created	NULL
by	NULL
the	NULL
twisted	NULL
superhelical	NULL
structure	NULL
is	NULL
highly	NULL
charged	NULL
and	NULL
proposed	NULL
to	NULL
be	NULL
the	NULL
interacting	NULL
surface	NULL
for	NULL
B-catenin	NULL
targets	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
a	NULL
second	NULL
armadillo	NULL
repeat	NULL
protein	NULL
,	NULL
yeast	NULL
importin	NULL
e	NULL
«	NULL
/karyopherin	NULL
«	NULL
/Srpl	NULL
,	NULL
was	NULL
recently	NULL
determined	NULL
,	NULL
and	NULL
while	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
its	NULL
9-	NULL
or	NULL
10-arm	NULL
repeat	NULL
array	NULL
is	NULL
only	NULL
17	NULL
%	NULL
similar	NULL
to	NULL
B-catenin	NULL
,	NULL
the	NULL
repeats	NULL
fold	NULL
into	NULL
a	NULL
similar	NULL
twisted	NULL
structure	NULL
with	NULL
a	NULL
groove	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Importin	NULL
«	NULL
,	NULL
and	NULL
a	NULL
second	NULL
arm	NULL
repeat	NULL
protein	NULL
,	NULL
importin	NULL
B	NULL
,	NULL
function	NULL
together	NULL
as	NULL
receptors	NULL
for	NULL
nuclear	NULL
localization	NULL
signals	NULL
(	NULL
NLSs	NULL
)	NULL
in	NULL
proteins	NULL
(	NULL
26	NULL
,	NULL
47	NULL
)	NULL
.	NULL

NLSs	NULL
are	NULL
highly	NULL
basic	NULL
,	NULL
whereas	NULL
B-catenin	NULL
targets	NULL
are	NULL
enriched	NULL
in	NULL
acidic	NULL
residues	NULL
.	NULL

Thus	NULL
,	NULL
even	NULL
though	NULL
arm	NULL
repeat	NULL
arrays	NULL
are	NULL
found	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
proteins	NULL
and	NULL
the	NULL
amino	NULL
acid	NULL
sequences	NULL
of	NULL
their	NULL
targets	NULL
vary	NULL
,	NULL
there	NULL
are	NULL
unifying	NULL
structural	NULL
similarities	NULL
in	NULL
the	NULL
way	NULL
these	NULL
proteins	NULL
bind	NULL
to	NULL
their	NULL
targets	NULL
.	NULL

A	NULL
major	NULL
unanswered	NULL
question	NULL
is	NULL
how	NULL
B-catenin	NULL
localizes	NULL
to	NULL
different	NULL
subcellular	NULL
compartments	NULL
.	NULL

For	NULL
example	NULL
,	NULL
since	NULL
B-catenin	NULL
does	NULL
not	NULL
have	NULL
an	NULL
obvious	NULL
NLS	NULL
for	NULL
importin	NULL
«	NULL
/B	NULL
receptors	NULL
,	NULL
4504	NULL
PRIEVE	NULL
AND	NULL
WATERMAN	NULL
it	NULL
was	NULL
proposed	NULL
that	NULL
B-catenin	NULL
must	NULL
enter	NULL
the	NULL
nucleus	NULL
by	NULL
binding	NULL
to	NULL
NLS-containing	NULL
LEF/TCF	NULL
transcription	NULL
factors	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
29	NULL
,	NULL
33	NULL
,	NULL
43	NULL
,	NULL
44	NULL
)	NULL
.	NULL

An	NULL
alternative	NULL
model	NULL
,	NULL
in	NULL
which	NULL
B-catenin	NULL
can	NULL
access	NULL
the	NULL
nucleus	NULL
independently	NULL
of	NULL
LEF/TCF	NULL
binding	NULL
(	NULL
17	NULL
)	NULL
,	NULL
has	NULL
been	NULL
proposed	NULL
.	NULL

This	NULL
model	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
study	NULL
of	NULL
nuclear	NULL
localization	NULL
of	NULL
recombinant	NULL
B-catenin	NULL
in	NULL
digitonin-permeabilized	NULL
cells	NULL
where	NULL
B-catenin	NULL
entered	NULL
the	NULL
nucleus	NULL
on	NULL
its	NULL
own	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exogenously	NULL
added	NULL
extract	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
inference	NULL
from	NULL
this	NULL
study	NULL
was	NULL
that	NULL
B-catenin	NULL
transport	NULL
was	NULL
independent	NULL
of	NULL
importin/karyopherins	NULL
and	NULL
also	NULL
of	NULL
any	NULL
LEF/TCF	NULL
protein	NULL
.	NULL

In	NULL
the	NULL
nucleus	NULL
,	NULL
B-catenin	NULL
is	NULL
known	NULL
to	NULL
interact	NULL
with	NULL
at	NULL
least	NULL
one	NULL
class	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
the	NULL
LEF/TCF	NULL
family	NULL
of	NULL
proteins	NULL
(	NULL
36	NULL
,	NULL
44	NULL
,	NULL
62	NULL
,	NULL
64	NULL
,	NULL
66	NULL
)	NULL
.	NULL

LEF/TCF	NULL
factors	NULL
are	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
that	NULL
function	NULL
as	NULL
context-dependent	NULL
transcription	NULL
factors	NULL
,	NULL
unable	NULL
to	NULL
work	NULL
on	NULL
their	NULL
own	NULL
but	NULL
requiring	NULL
the	NULL
cooperative	NULL
effort	NULL
of	NULL
adjacent	NULL
DNA	NULL
binding	NULL
transcription	NULL
proteins	NULL
or	NULL
non-DNA	NULL
binding	NULL
cofactors	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
.	NULL

LEF/	NULL
TCF	NULL
proteins	NULL
have	NULL
a	NULL
single	NULL
HMG	NULL
(	NULL
high-mobility-group	NULL
)	NULL
DNA	NULL
binding	NULL
domain	NULL
that	NULL
includes	NULL
an	NULL
HMG	NULL
box	NULL
,	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
DNA	NULL
binding-bending	NULL
motif	NULL
,	NULL
and	NULL
a	NULL
B	NULL
box	NULL
,	NULL
a	NULL
very	NULL
basic	NULL
cluster	NULL
of	NULL
8	NULL
or	NULL
9	NULL
aa	NULL
with	NULL
dual	NULL
functions	NULL
in	NULL
DNA	NULL
binding	NULL
and	NULL
nuclear	NULL
localization	NULL
(	NULL
20	NULL
,	NULL
23	NULL
,	NULL
40	NULL
,	NULL
54	NULL
)	NULL
.	NULL

B-Catenin	NULL
binds	NULL
to	NULL
a	NULL
region	NULL
within	NULL
the	NULL
first	NULL
56	NULL
aa	NULL
of	NULL
all	NULL
known	NULL
LEF/TCF	NULL
proteins	NULL
(	NULL
7	NULL
,	NULL
29	NULL
,	NULL
44	NULL
)	NULL
.	NULL

The	NULL
highly	NULL
conserved	NULL
B-catenin	NULL
binding	NULL
domain	NULL
in	NULL
LEF/TCF	NULL
proteins	NULL
is	NULL
separate	NULL
and	NULL
independent	NULL
from	NULL
the	NULL
HMG	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
which	NULL
is	NULL
located	NULL
in	NULL
the	NULL
middle	NULL
or	NULL
near	NULL
the	NULL
C	NULL
terminus	NULL
.	NULL

A	NULL
model	NULL
has	NULL
been	NULL
proposed	NULL
whereby	NULL
the	NULL
tethering	NULL
of	NULL
B-catenin	NULL
to	NULL
promoters	NULL
or	NULL
enhancers	NULL
by	NULL
LEF/TCF	NULL
factors	NULL
enables	NULL
a	NULL
transcription	NULL
activation	NULL
domain	NULL
in	NULL
B-catenin	NULL
,	NULL
perhaps	NULL
in	NULL
cooperation	NULL
with	NULL
LEF/TCF	NULL
sequences	NULL
,	NULL
to	NULL
regulate	NULL
transcription	NULL
of	NULL
Wnt-responsive	NULL
genes	NULL
(	NULL
27	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Reporter	NULL
plasmids	NULL
containing	NULL
only	NULL
multimerized	NULL
LEF/TCF	NULL
binding	NULL
sites	NULL
are	NULL
activated	NULL
by	NULL
this	NULL
complex	NULL
in	NULL
a	NULL
context-independent	NULL
manner	NULL
that	NULL
apparently	NULL
does	NULL
not	NULL
require	NULL
additional	NULL
factors	NULL
binding	NULL
to	NULL
flanking	NULL
regulatory	NULL
elements	NULL
(	NULL
27	NULL
,	NULL
29	NULL
,	NULL
36	NULL
,	NULL
44	NULL
,	NULL
45	NULL
,	NULL
53	NULL
,	NULL
59	NULL
,	NULL
63	NULL
)	NULL
.	NULL

However	NULL
,	NULL
whether	NULL
there	NULL
is	NULL
a	NULL
requirement	NULL
for	NULL
additional	NULL
factors	NULL
that	NULL
do	NULL
not	NULL
bind	NULL
DNA	NULL
is	NULL
not	NULL
known	NULL
.	NULL

We	NULL
have	NULL
constructed	NULL
a	NULL
deletion	NULL
mutant	NULL
that	NULL
does	NULL
not	NULL
bind	NULL
LEF/TCF	NULL
proteins	NULL
and	NULL
have	NULL
used	NULL
this	NULL
mutant	NULL
protein	NULL
to	NULL
explore	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
B-catenin	NULL
accumulates	NULL
in	NULL
nuclei	NULL
and	NULL
activates	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
show	NULL
that	NULL
B-catenin	NULL
localizes	NULL
to	NULL
nuclei	NULL
independently	NULL
of	NULL
its	NULL
interaction	NULL
with	NULL
LEF/TCF	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
in	NULL
the	NULL
nucleus	NULL
B-catenin	NULL
cooperates	NULL
with	NULL
LEF-1	NULL
and	NULL
perhaps	NULL
at	NULL
least	NULL
one	NULL
other	NULL
factor	NULL
to	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
,	NULL
DNA	NULL
transfections	NULL
,	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
assays	NULL
.	NULL

Cos-1	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
high-glucose	NULL
(	NULL
4.5-g/1	NULL
)	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
Gibco	NULL
)	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Eagle	NULL
's	NULL
minimum	NULL
essential	NULL
medium	NULL
with	NULL
nonessential	NULL
amino	NULL
acids	NULL
(	NULL
Irvine	NULL
Scientific	NULL
)	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Irvine	NULL
Scientific	NULL
)	NULL
.	NULL

All	NULL
media	NULL
contained	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Irvine	NULL
Scientific	NULL
)	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
,	NULL
250	NULL
ng	NULL
of	NULL
amphotericin	NULL
B	NULL
(	NULL
Gibco	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
50	NULL
M	NULL
B-mercaptoethanol	NULL
.	NULL

Cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
at	NULL
37°C	NULL
.	NULL

Cos-1	NULL
,	NULL
293	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
.	NULL

Normal	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
were	NULL
prepared	NULL
and	NULL
transfected	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

For	NULL
reporter	NULL
gene	NULL
expression	NULL
,	NULL
1	NULL
g	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
plasmid	NULL
containing	NULL
five	NULL
tandemly	NULL
repeated	NULL
Gal4	NULL
recognition	NULL
elements	NULL
upstream	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
P.	NULL
Carlsson	NULL
,	NULL
Goteborg	NULL
University	NULL
,	NULL
Goteborg	NULL
,	NULL
Sweden	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
various	NULL
amounts	NULL
of	NULL
G4LEF-1	NULL
,	NULL
B-catenin	NULL
,	NULL
and	NULL
control	NULL
expression	NULL
plasmids	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
Top	NULL
TK	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
H.	NULL
Clevers	NULL
,	NULL
University	NULL
of	NULL
Utrecht	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
10	NULL
g	NULL
each	NULL
of	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
wild-type	NULL
LEF-1	NULL
expression	NULL
plasmids	NULL
for	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
PBMCs	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
15	NULL
to	NULL
24	NULL
h	NULL
posttransfection	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
luciferase	NULL
activity	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
42	NULL
)	NULL
.	NULL

To	NULL
normalize	NULL
between	NULL
transfections	NULL
,	NULL
0.5	NULL
mg	NULL
of	NULL
LacZ	NULL
expression	NULL
plasmid	NULL
was	NULL
included	NULL
in	NULL
each	NULL
sample	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
was	NULL
determined	NULL
with	NULL
the	NULL
Galacto-Light/Plus	NULL
kit	NULL
(	NULL
Tropix	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Plasmid	NULL
construction	NULL
.	NULL

c-Myc	NULL
epitope-tagged	NULL
Xenopus	NULL
full-length	NULL
B-catenin	NULL
from	NULL
pCS2	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
B.	NULL
Gumbiner	NULL
,	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
pBluescript	NULL
at	NULL
the	NULL
BamHI	NULL
and	NULL
HinclI	NULL
sites	NULL
.	NULL

An	NULL
internal	NULL
deletion	NULL
of	NULL
aa	NULL
346	NULL
to	NULL
364	NULL
of	NULL
B-catenin	NULL
(	NULL
A19	NULL
B-catenin	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
digesting	NULL
B-catenin	NULL
in	NULL
pBluescript	NULL
with	NULL
Af/II	NULL
and	NULL
HindIII	NULL
.	NULL

Blunt	NULL
ends	NULL
were	NULL
generated	NULL
with	NULL
Klenow	NULL
enzyme	NULL
,	NULL
and	NULL
the	NULL
ends	NULL
were	NULL
religated	NULL
.	NULL

A19	NULL
B-catenin	NULL
was	NULL
then	NULL
transferred	NULL
to	NULL
pCS2	NULL
in	NULL
the	NULL
same	NULL
orientation	NULL
as	NULL
B-catenin	NULL
in	NULL
pCS2	NULL
.	NULL

An	NULL
N-terminal	NULL
deletion	NULL
of	NULL
the	NULL
first	NULL
148	NULL
aa	NULL
of	NULL
A19	NULL
B-catenin	NULL
(	NULL
ANA19	NULL
B-catenin	NULL
)	NULL
was	NULL
constructed	NULL
by	NULL
digesting	NULL
MT10	NULL
B-catenin	NULL
in	NULL
pCS2	NULL
(	NULL
aa	NULL
149	NULL
to	NULL
525	NULL
)	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
B.	NULL
Gumbiner	NULL
)	NULL
with	NULL
XhoI	NULL
and	NULL
SnaBI	NULL
and	NULL
replacing	NULL
this	NULL
fragment	NULL
with	NULL
a	NULL
fragment	NULL
from	NULL
A19	NULL
B-catenin	NULL
digested	NULL
at	NULL
the	NULL
identical	NULL
sites	NULL
.	NULL

All	NULL
mutations	NULL
were	NULL
sequenced	NULL
to	NULL
ensure	NULL
that	NULL
no	NULL
second-site	NULL
mutations	NULL
were	NULL
introduced	NULL
during	NULL
the	NULL
cloning	NULL
procedure	NULL
.	NULL

Construction	NULL
of	NULL
G4LEF	NULL
,	NULL
G4LEF	NULL
(	NULL
aa	NULL
80	NULL
to	NULL
256	NULL
)	NULL
,	NULL
FL	NULL
LEF	NULL
,	NULL
G4VP16	NULL
,	NULL
and	NULL
ANLEF	NULL
(	NULL
aa	NULL
67	NULL
to	NULL
399	NULL
)	NULL
is	NULL
mentioned	NULL
elsewhere	NULL
(	NULL
11	NULL
)	NULL
.	NULL

GST	NULL
fusion	NULL
protein	NULL
purification	NULL
.	NULL

Glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
and	NULL
full-length	NULL
GST-hLEF-1	NULL
were	NULL
purified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
54	NULL
)	NULL
.	NULL

GST-importin-B	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
S.	NULL
A.	NULL
Adam	NULL
,	NULL
Northwestern	NULL
University	NULL
)	NULL
was	NULL
purified	NULL
as	NULL
above	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
mM	NULL
ZnSO	NULL
.	NULL

In	NULL
vitro	NULL
binding	NULL
and	NULL
immunoprecipitation	NULL
assays	NULL
.	NULL

Radiolabeled	NULL
full-length	NULL
B-catenin	NULL
,	NULL
A19	NULL
B-catenin	NULL
,	NULL
the	NULL
C-terminal	NULL
tail	NULL
of	NULL
E-cadherin	NULL
(	NULL
generous	NULL
gift	NULL
of	NULL
P.	NULL
Polakis	NULL
,	NULL
Onyx	NULL
Pharmaceuticals	NULL
)	NULL
,	NULL
full-length	NULL
pendulin/Rch1/importin-a2	NULL
,	NULL
and	NULL
an	NULL
N-terminal	NULL
deletion	NULL
of	NULL
pendulin	NULL
(	NULL
aa	NULL
62	NULL
to	NULL
529	NULL
[	NULL
AN	NULL
importin-	NULL
«	NULL
2	NULL
]	NULL
)	NULL
(	NULL
55	NULL
)	NULL
were	NULL
prepared	NULL
with	NULL
a	NULL
coupled	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
(	NULL
DuPont-NEN	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
55	NULL
)	NULL
.	NULL

For	NULL
the	NULL
coimmunoprecipitation	NULL
assay	NULL
,	NULL
293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
plasmids	NULL
described	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
washed	NULL
once	NULL
in	NULL
1	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

Each	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
ice-cold	NULL
IP	NULL
buffer	NULL
,	NULL
which	NULL
contains	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
NaVO	NULL
,	NULL
,	NULL
20	NULL
ug	NULL
of	NULL
soybean	NULL
trypsin	NULL
inhibitor	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
4	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
pepstatin	NULL
A	NULL
per	NULL
ml	NULL
.	NULL

Lysates	NULL
were	NULL
microcentrifuged	NULL
at	NULL
14,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Two	NULL
microliters	NULL
of	NULL
an	NULL
anti-c-Myc	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
(	NULL
9E10	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
)	NULL
was	NULL
added	NULL
to	NULL
each	NULL
cleared	NULL
lysate	NULL
and	NULL
incubated	NULL
on	NULL
a	NULL
rotating	NULL
platform	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

Forty	NULL
microliters	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
diluted	NULL
in	NULL
IP	NULL
buffer	NULL
was	NULL
added	NULL
to	NULL
each	NULL
lysate	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
precipitates	NULL
were	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
2,000	NULL
rpm	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
IP	NULL
buffer	NULL
for	NULL
each	NULL
wash	NULL
,	NULL
and	NULL
boiled	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
protein	NULL
A-purified	NULL
hLEF-1	NULL
polyclonal	NULL
anti-serum	NULL
and	NULL
a	NULL
secondary	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
antibody	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
detection	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
(	NULL
Am-ersham	NULL
)	NULL
.	NULL

In	NULL
samples	NULL
with	NULL
additional	NULL
hLEF-1	NULL
recombinant	NULL
protein	NULL
,	NULL
5	NULL
ug	NULL
(	NULL
100	NULL
pmo	NULL
!	NULL
)	NULL

of	NULL
recombinant	NULL
,	NULL
purified	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
(	NULL
46a	NULL
)	NULL
was	NULL
added	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
on	NULL
a	NULL
rotating	NULL
platform	NULL
at	NULL
4°C	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
anti-c-Myc	NULL
antibody	NULL
.	NULL

For	NULL
normalizing	NULL
levels	NULL
of	NULL
B-catenin	NULL
,	NULL
the	NULL
immunoblot	NULL
was	NULL
stripped	NULL
and	NULL
reblotted	NULL
with	NULL
anti-c-Myc	NULL
MAb	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Amersham	NULL
)	NULL
and	NULL
detection	NULL
with	NULL
the	NULL
ECL	NULL
kit	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
coimmunoprecipitation	NULL
assay	NULL
represented	NULL
by	NULL
Fig	NULL
.	NULL

2C	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
46	NULL
)	NULL
except	NULL
as	NULL
follows	NULL
.	NULL

Five	NULL
microliters	NULL
of	NULL
*°S-labeled	NULL
in	NULL
vitro-translated	NULL
wild-type	NULL
or	NULL
A19	NULL
B-catenin	NULL
was	NULL
incubated	NULL
with	NULL
1.5	NULL
ug	NULL
of	NULL
purified	NULL
recombinant	NULL
APC2	NULL
(	NULL
aa	NULL
1034	NULL
to	NULL
2130	NULL
)	NULL
,	NULL
APC3	NULL
(	NULL
aa	NULL
2130	NULL
to	NULL
2844	NULL
)	NULL
,	NULL
or	NULL
axin	NULL
(	NULL
aa	NULL
320	NULL
to	NULL
530	NULL
)	NULL
(	NULL
generous	NULL
gifts	NULL
from	NULL
P.	NULL
Polakis	NULL
,	NULL
Onyx	NULL
Pharmaceuticals	NULL
)	NULL
or	NULL
no	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
volume	NULL
of	NULL
the	NULL
mixture	NULL
was	NULL
brought	NULL
to	NULL
30	NULL
pl	NULL
with	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
plus	NULL
0.2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
Glu-Glu	NULL
antibody	NULL
(	NULL
gift	NULL
of	NULL
P.	NULL
Polakis	NULL
)	NULL
and	NULL
10	NULL
ul	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
were	NULL
added	NULL
to	NULL
immunoprecipitate	NULL
Glu-Glu-tagged	NULL
APC2	NULL
,	NULL
APC3	NULL
,	NULL
and	NULL
axin	NULL
.	NULL

For	NULL
the	NULL
in	NULL
vitro	NULL
coimmunoprecipitation	NULL
assay	NULL
represented	NULL
by	NULL
Fig	NULL
.	NULL

2D	NULL
,	NULL
S-labeled	NULL
in	NULL
vitro-translated	NULL
C-terminal	NULL
tail	NULL
of	NULL
E-cadherin	NULL
was	NULL
incubated	NULL
with	NULL
either	NULL
radiolabeled	NULL
full-length	NULL
B-catenin	NULL
or	NULL
A19	NULL
B-catenin	NULL
in	NULL
TBST	NULL
(	NULL
200	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.0	NULL
]	NULL
,	NULL
0.2	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
with	NULL
0.2	NULL
%	NULL
BSA	NULL
in	NULL
a	NULL
100-pl	NULL
total	NULL
volume	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
on	NULL
a	NULL
rotating	NULL
platform	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
anti-c-Myc	NULL
MAb	NULL
and	NULL
20	NULL
pl	NULL
of	NULL
a	NULL
50	NULL
%	NULL
slurry	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
washed	NULL
in	NULL
TBST-0.2	NULL
%	NULL
BSA	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
on	NULL
a	NULL
rotating	NULL
platform	NULL
.	NULL

The	NULL
precipitates	NULL
were	NULL
centrifuged	NULL
for	NULL
5	NULL
min	NULL
at	NULL
2,000	NULL
rpm	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
TBST	NULL
for	NULL
each	NULL
wash	NULL
,	NULL
and	NULL
boiled	NULL
in	NULL
15	NULL
pl	NULL
of	NULL
2x	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
the	NULL
gel	NULL
was	NULL
treated	NULL
with	NULL
En	NULL
Hance	NULL
(	NULL
DuPont-NEN	NULL
)	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
overnight	NULL
.	NULL

Fluorescence	NULL
microscopy	NULL
.	NULL

Full-length	NULL
B-catenin	NULL
in	NULL
pCS2	NULL
,	NULL
MT10	NULL
in	NULL
pCS2	NULL
(	NULL
generous	NULL
gifts	NULL
of	NULL
B.	NULL
Gumbiner	NULL
,	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
N.Y.	NULL
)	NULL
,	NULL
and	NULL
A19	NULL
B-catenin	NULL
in	NULL
pCS2	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
Cos-1	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
followed	NULL
by	NULL
immunofluorescence	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
54	NULL
)	NULL
,	NULL
with	NULL
anti-c-Myc	NULL
MAb	NULL
and	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
or	NULL
Texas	NULL
red-conjugated	NULL
anti-mouse	NULL
(	NULL
Amersham	NULL
)	NULL
antibodies	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
1	NULL
%	NULL
PBS	NULL
and	NULL
diluted	NULL
to	NULL
~1	NULL
X	NULL
10°	NULL
cells/ml	NULL
,	NULL
and	NULL
100	NULL
pl	NULL
of	NULL
cells	NULL
were	NULL
cytospun	NULL
onto	NULL
poly-L-lysine-coated	NULL
slides	NULL
prior	NULL
to	NULL
fixation	NULL
.	NULL

For	NULL
detection	NULL
of	NULL
endogenous	NULL
B-catenin	NULL
,	NULL
anti-B-catenin	NULL
MAb	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
was	NULL
used	NULL
.	NULL

Nuclei	NULL
were	NULL
stained	NULL
with	NULL
4',6-diamidino-2-phenylindole	NULL
(	NULL
DAPI	NULL
)	NULL
prior	NULL
to	NULL
being	NULL
mounted	NULL
slides	NULL
with	NULL
mounting	NULL
media	NULL
.	NULL

Normal	NULL
human	NULL
PBMCs	NULL
were	NULL
prepared	NULL
and	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
NUCLEAR	NULL
LOCALIZATION	NULL
AND	NULL
GENE	NULL
ACTIVATION	NULL
BY	NULL
g-CATENIN	NULL
A	NULL
1	NULL
141	NULL
A	NULL
6g4	NULL
781	NULL
WT	NULL
_|112|3|4|5	NULL
[	NULL
6|7|s|9|1o1o|11|1zku—	NULL
345	NULL
365	NULL
(	NULL
\	NULL
A19	NULL
_|1|2|3|4|5	NULL
6|7|8|9|1010|11|12_	NULL
149	NULL
\	NULL
525	NULL
MT10	NULL
1|2|3	NULL
|4|5	NULL
|s|7	NULL
|a|9|	NULL
149	NULL
345	NULL
365	NULL
(	NULL
\	NULL
ANA19	NULL
|1I2|3f4|5	NULL
s|7|8|9|1o|1o|11|12—	NULL
4505	NULL
H2	NULL
H3	NULL
m	NULL
moaned	NULL
arm	NULL
-	NULL
N	NULL
YQDDAE	NULL
LATR	NULL
AIPELTKLLN	NULL
--	NULL
DE	NULL
-	NULL
DQVVVNKAAVMVHQLSK	NULL
arm2	NULL
K	NULL
-	NULL
EASRHA	NULL
-	NULL
IMRSPQMVSAIVRTMON	NULL
-	NULL
TN	NULL
-	NULL
DVETARCTAGTLHNLSH	NULL
arm3	NULL
H	NULL
RECLLA	NULL
-	NULL
IFKS	NULL
CCIPALVKML	NULL
G	NULL
--	NULL
SP	NULL
VDSVLFYAITTLHNLLL	NULL
arm4	NULL
-	NULL
HQ	NULL
-	NULL
ECAKMA	NULL
VRLA	NULL
CCLOKMVALL	NULL
N-	NULL
KT	NULL
-	NULL
NVKFLAITTDCLQILAY	NULL
arm5	NULL
-	NULL
CN	NULL
QESKLI	NULL
-	NULL
ILAS	NULL
GCGPQALVNIMRT	NULL
-	NULL
YS	NULL
_-	NULL
YEKLLWTPTSRVLKYVLSY	NULL
armé	NULL
C	NULL
_	NULL
SSNKPA	NULL
IVEA	NULL
GG	NULL
@	NULL
MQALCLHLT	NULL
-	NULL
DS	NULL
SQRLVONCLWTLRNLSD	NULL
arm7	NULL
-	NULL
AA	NULL
TK	NULL
QEGM	NULL
-	NULL
ECLLCTLVOLLG	NULL
--	NULL
SD	NULL
-	NULL
DINVVTCAAGILSNLTC	NULL
armg	NULL
-	NULL
NN	NULL
-	NULL
YKNKMM	NULL
VCQV	NULL
CGIEALVRTVLRA	NULL
GD	NULL
-	NULL
REDITEPAICALRHLTS	NULL
arm9	NULL
-	NULL
RHOEAEMAQNA	NULL
-	NULL
VRLH	NULL
YGLPVVVKLLH	NULL
PPS	NULL
-	NULL
HWPLIKATVCLIRNLAL	NULL
arm1i0	NULL
-	NULL
C-	NULL
PANHAP	NULL
LREQ	NULL
CATPRLVQLLVR	NULL
EETIVECCTCALHILAR	NULL
QGEEEEiTSIGGTQ§553EEﬁR	NULL
armil	NULL
-	NULL
D-	NULL
IHNRIV	NULL
IRCL	NULL
NTIPLFVQLLY	NULL
--	NULL
SP	NULL
-	NULL
TENIQRVAACVLCDVAQ	NULL
arm12	NULL
-	NULL
D	NULL
-	NULL
KEAAEA	NULL
IEAE	NULL
CATAPLTELLH	NULL
SR	NULL
-	NULL
NEGVATYAAAVLFRMSE	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
and	NULL
structure	NULL
of	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
of	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
deletion	NULL
mutants	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
of	NULL
wild-type	NULL
B-catenin	NULL
,	NULL
a	NULL
19-aa	NULL
deletion	NULL
mutant	NULL
of	NULL
B-catenin	NULL
(	NULL
A19	NULL
)	NULL
;	NULL
MT1O0	NULL
B-catenin	NULL
,	NULL
which	NULL
contains	NULL
only	NULL
the	NULL
first	NULL
nine	NULL
arm	NULL
repeats	NULL
and	NULL
no	NULL
flanking	NULL
sequences	NULL
;	NULL
and	NULL
ANA19	NULL
,	NULL
which	NULL
is	NULL
identical	NULL
to	NULL
A19	NULL
but	NULL
contains	NULL
a	NULL
deletion	NULL
of	NULL
the	NULL
first	NULL
148	NULL
aa	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Amino	NULL
acid	NULL
alignment	NULL
of	NULL
the	NULL
arm	NULL
repeats	NULL
of	NULL
B-catenin	NULL
.	NULL

According	NULL
to	NULL
the	NULL
recently	NULL
solved	NULL
structure	NULL
for	NULL
B-catenin	NULL
,	NULL
each	NULL
arm	NULL
repeat	NULL
consists	NULL
of	NULL
three	NULL
alpha-helices	NULL
,	NULL
which	NULL
are	NULL
denoted	NULL
by	NULL
H1	NULL
,	NULL
H2	NULL
,	NULL
and	NULL
H3	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
deleted	NULL
in	NULL
the	NULL
A19	NULL
B-catenin	NULL
mutant	NULL
is	NULL
in	NULL
boldface	NULL
type	NULL
and	NULL
underlined	NULL
.	NULL

transfected	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
PBMCs	NULL
were	NULL
treated	NULL
with	NULL
media	NULL
containing	NULL
25	NULL
ng	NULL
of	NULL
phorbol-12-myristate-13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
per	NULL
ml	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
ionomycin	NULL
per	NULL
ml	NULL
or	NULL
with	NULL
media	NULL
containing	NULL
an	NULL
identical	NULL
amount	NULL
of	NULL
ethyl	NULL
alcohol	NULL
carrier	NULL
control	NULL
(	NULL
untreated	NULL
)	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

For	NULL
export	NULL
of	NULL
B-catenin	NULL
,	NULL
10	NULL
g	NULL
of	NULL
actinomycin	NULL
D	NULL
per	NULL
ml	NULL
and	NULL
100	NULL
pg	NULL
of	NULL
cycloheximide	NULL
per	NULL
ml	NULL
were	NULL
added	NULL
to	NULL
PBMCs	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
and	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
3	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
containing	NULL
identical	NULL
amounts	NULL
of	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
treated	NULL
cells	NULL
,	NULL
PBS	NULL
alone	NULL
for	NULL
untreated	NULL
cells	NULL
,	NULL
and	NULL
PMA	NULL
,	NULL
ionomycin	NULL
,	NULL
actinomycin	NULL
D	NULL
,	NULL
and	NULL
cycloheximide	NULL
for	NULL
export	NULL
conditions	NULL
and	NULL
then	NULL
resuspended	NULL
to	NULL
~1	NULL
x	NULL
10°	NULL
cells/ml	NULL
.	NULL

One	NULL
hundred	NULL
microliters	NULL
of	NULL
this	NULL
cell	NULL
preparation	NULL
was	NULL
cytospun	NULL
onto	NULL
poly-L-lysine-coated	NULL
slides	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
in	NULL
3.7	NULL
%	NULL
formaldehyde-1x	NULL
PBS	NULL
,	NULL
and	NULL
immunofluorescence	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Slides	NULL
were	NULL
examined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
55	NULL
)	NULL
.	NULL

RESULTS	NULL
An	NULL
internal	NULL
deletion	NULL
of	NULL
arm	NULL
repeat	NULL
6	NULL
destroys	NULL
LEF/TCF	NULL
binding	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
determining	NULL
which	NULL
region	NULL
of	NULL
the	NULL
B-catenin	NULL
arm	NULL
repeat	NULL
array	NULL
recognizes	NULL
LEF/TCF	NULL
proteins	NULL
,	NULL
we	NULL
found	NULL
that	NULL
a	NULL
deletion	NULL
of	NULL
part	NULL
of	NULL
the	NULL
sixth	NULL
arm	NULL
repeat	NULL
could	NULL
destroy	NULL
binding	NULL
.	NULL

Figure	NULL
1A	NULL
depicts	NULL
the	NULL
location	NULL
and	NULL
scale	NULL
of	NULL
the	NULL
deletion	NULL
mutation	NULL
(	NULL
A19	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
arrangement	NULL
of	NULL
alpha-helices	NULL
in	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
,	NULL
the	NULL
19-aa	NULL
deletion	NULL
removes	NULL
the	NULL
final	NULL
four	NULL
residues	NULL
of	NULL
helix	NULL
3	NULL
of	NULL
the	NULL
fifth	NULL
arm	NULL
repeat	NULL
and	NULL
15	NULL
aa	NULL
(	NULL
helix	NULL
1	NULL
and	NULL
2	NULL
)	NULL
of	NULL
the	NULL
sixth	NULL
arm	NULL
repeat	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

This	NULL
region	NULL
is	NULL
well	NULL
conserved	NULL
between	NULL
all	NULL
B-catenin	NULL
orthologs	NULL
as	NULL
well	NULL
as	NULL
cate-nin-related	NULL
proteins	NULL
such	NULL
as	NULL
plakoglobin	NULL
.	NULL

Mutant	NULL
A19	NULL
was	NULL
tested	NULL
for	NULL
binding	NULL
to	NULL
human	NULL
LEF-1	NULL
in	NULL
a	NULL
GST	NULL
pull-down	NULL
exper-iment	NULL
.	NULL

Wild-type	NULL
B-catenin	NULL
and	NULL
A19	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
°°SJme-thionine	NULL
by	NULL
in	NULL
vitro	NULL
transcription/translation	NULL
procedures	NULL
and	NULL
incubated	NULL
with	NULL
either	NULL
GST-LEF-1	NULL
or	NULL
GST	NULL
recombinant	NULL
fusion	NULL
protein	NULL
.	NULL

Figure	NULL
2A	NULL
shows	NULL
that	NULL
while	NULL
wild-type	NULL
B-catenin	NULL
binds	NULL
specifically	NULL
to	NULL
GST-LEF-1	NULL
,	NULL
the	NULL
A19	NULL
B-catenin	NULL
protein	NULL
does	NULL
not	NULL
bind	NULL
.	NULL

Neither	NULL
the	NULL
wild	NULL
type	NULL
nor	NULL
A19	NULL
binds	NULL
nonspecifically	NULL
to	NULL
the	NULL
GST	NULL
control	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
loss	NULL
of	NULL
LEF-1	NULL
binding	NULL
was	NULL
examined	NULL
in	NULL
vivo	NULL
in	NULL
transfected	NULL
293	NULL
embryonic	NULL
kidney	NULL
cells	NULL
.	NULL

A	NULL
eukaryotic	NULL
expression	NULL
vector	NULL
producing	NULL
Myc-tagged	NULL
wild-type	NULL
or	NULL
A19	NULL
B-catenin	NULL
protein	NULL
was	NULL
cotransfected	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
producing	NULL
wild-type	NULL
LEF-1	NULL
.	NULL

Extracts	NULL
from	NULL
these	NULL
transfected	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
anti-Myc	NULL
MAb	NULL
was	NULL
added	NULL
to	NULL
coimmunoprecipitate	NULL
B-catenin	NULL
and	NULL
interacting	NULL
proteins	NULL
.	NULL

Using	NULL
LEF-1	NULL
polyclonal	NULL
antisera	NULL
,	NULL
a	NULL
Western	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
determine	NULL
if	NULL
LEF-1	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
these	NULL
coimmunoprecipitates	NULL
.	NULL

Figure	NULL
2B	NULL
shows	NULL
that	NULL
LEF-1	NULL
interacts	NULL
with	NULL
wild-type	NULL
B-catenin	NULL
in	NULL
vivo	NULL
but	NULL
not	NULL
with	NULL
A19	NULL
B-catenin	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Five	NULL
micrograms	NULL
(	NULL
~1	NULL
x	NULL
10~'°	NULL
mol	NULL
)	NULL
of	NULL
recombinant	NULL
,	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
was	NULL
added	NULL
to	NULL
cell	NULL
extracts	NULL
to	NULL
determine	NULL
whether	NULL
a	NULL
weak	NULL
interaction	NULL
between	NULL
LEF-1	NULL
and	NULL
A19	NULL
could	NULL
be	NULL
detected	NULL
,	NULL
but	NULL
even	NULL
an	NULL
excess	NULL
amount	NULL
of	NULL
LEF-1	NULL
protein	NULL
was	NULL
unable	NULL
to	NULL
reveal	NULL
any	NULL
binding	NULL
to	NULL
A19	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

This	NULL
total	NULL
lack	NULL
of	NULL
an	NULL
interaction	NULL
is	NULL
not	NULL
due	NULL
to	NULL
differential	NULL
stability	NULL
of	NULL
the	NULL
A19	NULL
mutant	NULL
in	NULL
293	NULL
cells	NULL
,	NULL
because	NULL
reprobing	NULL
of	NULL
the	NULL
same	NULL
Western	NULL
blot	NULL
with	NULL
anti-Myc	NULL
antibody	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenin	NULL
proteins	NULL
are	NULL
nearly	NULL
the	NULL
same	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
and	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Western	NULL
analysis	NULL
of	NULL
total	NULL
cell	NULL
lysates	NULL
from	NULL
transiently	NULL
transfected	NULL
cells	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenin	NULL
vary	NULL
by	NULL
less	NULL
than	NULL
twofold	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Mutant	NULL
A19	NULL
binds	NULL
to	NULL
axin	NULL
but	NULL
is	NULL
defective	NULL
for	NULL
binding	NULL
to	NULL
APC	NULL
and	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
E-cadherin	NULL
.	NULL

Large	NULL
deletions	NULL
of	NULL
the	NULL
arm	NULL
repeat	NULL
region	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
destroy	NULL
binding	NULL
to	NULL
APC	NULL
,	NULL
axin	NULL
,	NULL
and	NULL
E-cadherin	NULL
(	NULL
18	NULL
,	NULL
31	NULL
,	NULL
32	NULL
,	NULL
48	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
the	NULL
much	NULL
smaller	NULL
A19	NULL
deletion	NULL
might	NULL
also	NULL
disrupt	NULL
interactions	NULL
with	NULL
these	NULL
three	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

Wild-type	NULL
B-catenin	NULL
4506	NULL
PRIEVE	NULL
AND	NULL
WATERMAN	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

wt	NULL
A19	NULL
A	NULL
10	NULL
%	NULL
input	NULL
GST	NULL
LEF	NULL
_	NULL
GST	NULL
C	NULL
gey	NULL
peg	NULL
peg	NULL
Kd	NULL
__	NULL
wt	NULL
A19	NULL
wt	NULL
A19	NULL
wt	NULL
A19	NULL
cmt	NULL
-oh	NULL
Tin	NULL
APC2	NULL
APC3	NULL
Axin	NULL
Cnt	NULL
__	NULL
Tin	NULL
APC2	NULL
APC3	NULL
Axin	NULL
Cnt	NULL
Chi®	NULL
aurea	NULL
-catenin	NULL
-	NULL
220-7	NULL
97.4-	NULL
-	NULL
>	NULL
oo-w=	NULL
$	NULL
e	NULL
-	NULL
-	NULL
-*	NULL
erd	NULL
66-	NULL
66-	NULL
46	NULL
46	NULL
B	NULL
D	NULL
purified	NULL
LEF	NULL
protein	NULL
control	NULL
vector	NULL
A	NULL
19	NULL
B-catenin	NULL
wt	NULL
B-catenin	NULL
LEF	NULL
LEF	NULL
Western	NULL
97	NULL
:	NULL
Myc	NULL
IP	NULL
«	NULL
<	NULL
p	NULL
<	NULL
LEF	NULL
FL	NULL
protein	NULL
i	NULL
«	NULL
lf	NULL
E-cadherin	NULL
Myc	NULL
Western	NULL
Myc	NULL
IP	NULL
97	NULL
e	NULL
was	NULL
Mi	NULL
Si	NULL
|	NULL
-ag	NULL
s-catenin	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Deletion	NULL
of	NULL
19	NULL
aa	NULL
within	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
of	NULL
B-catenin	NULL
disrupts	NULL
interaction	NULL
with	NULL
LEF-1	NULL
,	NULL
APC	NULL
,	NULL
and	NULL
E-cadherin	NULL
but	NULL
not	NULL
axin	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Wild-type	NULL
(	NULL
wt	NULL
)	NULL
B-catenin	NULL
and	NULL
a	NULL
19-aa	NULL
deletion	NULL
mutant	NULL
of	NULL
B-catenin	NULL
(	NULL
A19	NULL
)	NULL
were	NULL
produced	NULL
by	NULL
a	NULL
coupled	NULL
transcription/translation	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*°SJmethionine	NULL
.	NULL

These	NULL
proteins	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
GST-LEF-1	NULL
or	NULL
GST	NULL
alone	NULL
in	NULL
a	NULL
GST	NULL
pull-down	NULL
binding	NULL
assay	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
first	NULL
two	NULL
lanes	NULL
indicate	NULL
the	NULL
amount	NULL
of	NULL
B-catenin	NULL
protein	NULL
added	NULL
(	NULL
10	NULL
%	NULL
input	NULL
)	NULL
.	NULL

Glutathione	NULL
beads	NULL
are	NULL
able	NULL
to	NULL
cosediment	NULL
wild-type	NULL
B-catenin	NULL
with	NULL
GST-LEF-1	NULL
but	NULL
not	NULL
GST	NULL
alone	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
A19	NULL
B-catenin	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
GST-LEF-1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
293	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
plasmids	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Anti-Myc	NULL
MAb	NULL
was	NULL
used	NULL
to	NULL
coimmunoprecipitate	NULL
B-catenin-associated	NULL
proteins	NULL
.	NULL

A	NULL
Western	NULL
blot	NULL
of	NULL
the	NULL
immunoprecipitates	NULL
was	NULL
probed	NULL
with	NULL
LEF-1	NULL
antisera	NULL
.	NULL

LEF-1	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
coimmunoprecipitates	NULL
with	NULL
wild-type	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
but	NULL
not	NULL
A19	NULL
B-catenin	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Purified	NULL
recombinant	NULL
LEF-1	NULL
protein	NULL
(	NULL
5	NULL
mg	NULL
)	NULL
added	NULL
to	NULL
cell	NULL
extract	NULL
prior	NULL
to	NULL
immunoprecipitation	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
is	NULL
able	NULL
to	NULL
interact	NULL
only	NULL
with	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
not	NULL
even	NULL
weakly	NULL
with	NULL
A19	NULL
B-catenin	NULL
.	NULL

In	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
a	NULL
control	NULL
eukaryotic	NULL
expression	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
with	NULL
either	NULL
LEF-1	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
wild-type	NULL
B-catenin	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
to	NULL
show	NULL
that	NULL
LEF-1	NULL
coimmunoprecipitates	NULL
specifically	NULL
by	NULL
association	NULL
with	NULL
B-catenin	NULL
and	NULL
not	NULL
nonspecifically	NULL
with	NULL
the	NULL
anti-Myc	NULL
MAb	NULL
.	NULL

The	NULL
same	NULL
Western	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
anti-Myc	NULL
MAb	NULL
to	NULL
determine	NULL
that	NULL
the	NULL
protein	NULL
levels	NULL
of	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenin	NULL
were	NULL
equivalent	NULL
.	NULL

(	NULL
C	NULL
)	NULL
In	NULL
vitro-translated	NULL
wild-type	NULL
or	NULL
A19	NULL
B-catenin	NULL
was	NULL
incubated	NULL
with	NULL
two	NULL
purified	NULL
APC	NULL
fragments	NULL
(	NULL
APC2	NULL
and	NULL
APC3	NULL
)	NULL
,	NULL
an	NULL
axin	NULL
fragment	NULL
(	NULL
Axin	NULL
)	NULL
,	NULL
or	NULL
no	NULL
protein	NULL
(	NULL
Cnt	NULL
)	NULL
.	NULL

Anti-Glu-Glu	NULL
antibody	NULL
and	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
were	NULL
added	NULL
in	NULL
a	NULL
coimmunoprecipitation	NULL
assay	NULL
.	NULL

Ten	NULL
percent	NULL
of	NULL
the	NULL
amount	NULL
of	NULL
B-catenin	NULL
protein	NULL
added	NULL
is	NULL
shown	NULL
(	NULL
Tin	NULL
)	NULL
.	NULL

APC2	NULL
and	NULL
axin	NULL
are	NULL
coimmunoprecipitated	NULL
with	NULL
wild-type	NULL
B-catenin	NULL
but	NULL
only	NULL
axin	NULL
is	NULL
coimmunoprecipitated	NULL
with	NULL
A19	NULL
B-catenin	NULL
.	NULL

(	NULL
D	NULL
)	NULL
In	NULL
vitro-translated	NULL
wild-type	NULL
or	NULL
A19	NULL
B-catenin	NULL
and	NULL
the	NULL
C-terminal	NULL
tail	NULL
of	NULL
E-cadherin	NULL
were	NULL
incubated	NULL
with	NULL
anti-Myc	NULL
MAb	NULL
and	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
in	NULL
a	NULL
coimmunoprecipitation	NULL
assay	NULL
.	NULL

E-cadherin	NULL
can	NULL
be	NULL
detected	NULL
in	NULL
coimmunoprecipitates	NULL
with	NULL
wild-type	NULL
but	NULL
not	NULL
A19	NULL
B-catenin	NULL
.	NULL

The	NULL
number	NULL
of	NULL
additional	NULL
bands	NULL
is	NULL
due	NULL
to	NULL
partial	NULL
translation	NULL
products	NULL
of	NULL
B-catenin	NULL
which	NULL
are	NULL
coimmunoprecipitated	NULL
with	NULL
anti-Myc	NULL
MAb	NULL
.	NULL

and	NULL
A19	NULL
mutant	NULL
proteins	NULL
were	NULL
in	NULL
vitro	NULL
translated	NULL
and	NULL
tested	NULL
for	NULL
APC	NULL
,	NULL
and	NULL
LEF/TCF	NULL
.	NULL

Alternatively	NULL
,	NULL
because	NULL
tandem	NULL
arm	NULL
rebinding	NULL
to	NULL
two	NULL
Glu-Glu-tagged	NULL
protein	NULL
fragments	NULL
of	NULL
APC	NULL
peats	NULL
are	NULL
interdependent	NULL
for	NULL
correct	NULL
folding	NULL
,	NULL
removal	NULL
of	NULL
these	NULL
(	NULL
APC2	NULL
and	NULL
APC3	NULL
)	NULL
and	NULL
one	NULL
Glu-Glu-tagged	NULL
protein	NULL
fragment	NULL
sequences	NULL
may	NULL
have	NULL
caused	NULL
structural	NULL
distortions	NULL
in	NULL
neighbor-of	NULL
axin	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

APC2	NULL
(	NULL
aa	NULL
1034	NULL
to	NULL
2130	NULL
)	NULL
and	NULL
axin	NULL
(	NULL
aa	NULL
320	NULL
to	NULL
ing	NULL
regions	NULL
of	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
.	NULL

However	NULL
,	NULL
this	NULL
region	NULL
must	NULL
530	NULL
)	NULL
each	NULL
contain	NULL
a	NULL
B-catenin	NULL
binding	NULL
domain	NULL
,	NULL
while	NULL
APC3	NULL
(	NULL
aa	NULL
not	NULL
be	NULL
grossly	NULL
misfolded	NULL
because	NULL
removal	NULL
of	NULL
half	NULL
of	NULL
the	NULL
sixth	NULL
2130	NULL
to	NULL
2844	NULL
)	NULL
does	NULL
not	NULL
and	NULL
serves	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
58	NULL
)	NULL
.	NULL

arm	NULL
repeat	NULL
does	NULL
not	NULL
disrupt	NULL
axin	NULL
recognition	NULL
of	NULL
arm	NULL
repeats	NULL
3	NULL
Anti-Glu-Glu	NULL
antibody	NULL
and	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
were	NULL
through	NULL
7	NULL
(	NULL
6	NULL
,	NULL
32	NULL
)	NULL
.	NULL

added	NULL
to	NULL
immunoprecipitate	NULL
Glu-Glu-tagged	NULL
protein	NULL
.	NULL

Wild-	NULL
Nuclear	NULL
localization	NULL
of	NULL
B-catenin	NULL
is	NULL
LEF/TCF	NULL
independent	NULL
.	NULL

type	NULL
B-catenin	NULL
coimmunoprecipitated	NULL
with	NULL
APC2	NULL
and	NULL
axin	NULL
but	NULL
Since	NULL
A19	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
LEF/TCF	NULL
proteins	NULL
,	NULL
this	NULL
mutant	NULL
not	NULL
with	NULL
APC3	NULL
or	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
alone	NULL
.	NULL

A19	NULL
mu-	NULL
allowed	NULL
us	NULL
to	NULL
test	NULL
the	NULL
model	NULL
that	NULL
B-catenin	NULL
can	NULL
move	NULL
into	NULL
the	NULL
tant	NULL
protein	NULL
coimmunoprecipitated	NULL
with	NULL
axin	NULL
at	NULL
levels	NULL
that	NULL
nucleus	NULL
independent	NULL
of	NULL
LEF/TCF	NULL
binding	NULL
in	NULL
vivo	NULL
.	NULL

Immunoflu-were	NULL
significantly	NULL
greater	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
wild-type	NULL
orescence	NULL
detection	NULL
of	NULL
transiently	NULL
expressed	NULL
B-catenin	NULL
protein	NULL
B-catenin	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
A19	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
APCZ	NULL
.	NULL

Next	NULL
,	NULL
wild-	NULL
in	NULL
Cos-1	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
to	NULL
determine	NULL
patterns	NULL
of	NULL
subcel-	NULL
type	NULL
B-catenin	NULL
or	NULL
A19	NULL
mutant	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
lular	NULL
localization	NULL
.	NULL

Overexpressed	NULL
B-catenin	NULL
was	NULL
detected	NULL
with	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
E-cadherin	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Anti-Mye	NULL
antibody	NULL
an	NULL
anti-Myc	NULL
MAb	NULL
.	NULL

Localization	NULL
of	NULL
transiently	NULL
expressed	NULL
pro-and	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
were	NULL
added	NULL
to	NULL
immunopre-	NULL
tein	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
endogenous	NULL
B-catenin	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
cipitate	NULL
Myc-tagged	NULL
B-catenin	NULL
protein	NULL
.	NULL

E-cadherin	NULL
coimmuno-	NULL
B	NULL
)	NULL
;	NULL
the	NULL
protein	NULL
localized	NULL
to	NULL
plasma	NULL
membrane	NULL
and	NULL
cytoplasmic	NULL
precipitated	NULL
with	NULL
wild-type	NULL
B-catenin	NULL
but	NULL
not	NULL
with	NULL
A19	NULL
.	NULL

Thus	NULL
,	NULL
sites	NULL
.	NULL

A	NULL
mutant	NULL
B-catenin	NULL
protein	NULL
(	NULL
MT10	NULL
)	NULL
,	NULL
missing	NULL
the	NULL
flanking	NULL
sequences	NULL
within	NULL
or	NULL
near	NULL
the	NULL
sixth	NULL
arm	NULL
repeat	NULL
are	NULL
required	NULL
for	NULL
NH-	NULL
and	NULL
COOH-terminal	NULL
regions	NULL
as	NULL
well	NULL
as	NULL
arm	NULL
repeats	NULL
10	NULL
binding	NULL
to	NULL
three	NULL
of	NULL
the	NULL
four	NULL
proteins	NULL
tested	NULL
.	NULL

These	NULL
sequences	NULL
through	NULL
12	NULL
,	NULL
was	NULL
also	NULL
observed	NULL
to	NULL
localize	NULL
to	NULL
membranes	NULL
and	NULL
could	NULL
be	NULL
directly	NULL
involved	NULL
in	NULL
interactions	NULL
with	NULL
E-cadherin	NULL
,	NULL
cytoplasm	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
3C	NULL
)	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
marked	NULL
contrast	NULL
,	NULL
most	NULL
of	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
wildtype	NULL
-catenin	NULL
anti-myc	NULL
DAPI	NULL
endogenous	NULL
-catenin	NULL
B	NULL
anti-B-catenin	NULL
DAPI	NULL
NUCLEAR	NULL
LOCALIZATION	NULL
AND	NULL
GENE	NULL
ACTIVATION	NULL
BY	NULL
B-CATENIN	NULL
_	NULL
4507	NULL
C	NULL
MT10	NULL
anti-myc	NULL
D	NULL
A19	NULL
B-catenin	NULL
anti-mye	NULL
DAPI	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

A19	NULL
B-catenin	NULL
localizes	NULL
constitutively	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Plasmids	NULL
encoding	NULL
Myc	NULL
epitope-tagged	NULL
wild-type	NULL
B-catenin	NULL
(	NULL
A	NULL
)	NULL
,	NULL
MTIO	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
A19	NULL
(	NULL
D	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
Cos-1	NULL
cells	NULL
.	NULL

Subcellular	NULL
localization	NULL
was	NULL
determined	NULL
48	NULL
h	NULL
later	NULL
by	NULL
immunofluorescence	NULL
with	NULL
anti-Myc	NULL
MAb	NULL
to	NULL
detect	NULL
transfected	NULL
B-catenin	NULL
expression	NULL
plasmids	NULL
or	NULL
anti-B-catenin	NULL
MAb	NULL
to	NULL
detect	NULL
endogenous	NULL
B-catenin	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
FITC	NULL
antimouse	NULL
or	NULL
Texas	NULL
red	NULL
antimouse	NULL
secondary	NULL
antibody	NULL
was	NULL
used	NULL
.	NULL

(	NULL
A	NULL
to	NULL
C	NULL
)	NULL
Wild-type	NULL
B-catenin	NULL
,	NULL
endogenous	NULL
B-catenin	NULL
,	NULL
and	NULL
MT1O	NULL
localize	NULL
to	NULL
various	NULL
sites	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Background	NULL
levels	NULL
are	NULL
higher	NULL
for	NULL
MT10	NULL
,	NULL
since	NULL
immunofluorescence	NULL
of	NULL
MT10	NULL
was	NULL
weak	NULL
and	NULL
exposure	NULL
times	NULL
were	NULL
longer	NULL
than	NULL
for	NULL
the	NULL
other	NULL
B-catenin	NULL
proteins	NULL
.	NULL

(	NULL
D	NULL
)	NULL
In	NULL
contrast	NULL
to	NULL
wild-type	NULL
and	NULL
MT10	NULL
B-catenin	NULL
,	NULL
A19	NULL
B-catenin	NULL
localizes	NULL
predominantly	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

DAPI	NULL
staining	NULL
of	NULL
DNA	NULL
indicates	NULL
the	NULL
locations	NULL
of	NULL
nuclei	NULL
.	NULL

the	NULL
A19	NULL
protein	NULL
was	NULL
present	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

This	NULL
surprising	NULL
pattern	NULL
of	NULL
nuclear	NULL
localization	NULL
directly	NULL
shows	NULL
that	NULL
B-catenin	NULL
can	NULL
move	NULL
into	NULL
the	NULL
nucleus	NULL
independently	NULL
of	NULL
LEF/	NULL
TCF	NULL
binding	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
B-catenin	NULL
gains	NULL
entry	NULL
to	NULL
the	NULL
nucleus	NULL
is	NULL
not	NULL
understood	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
recombinant	NULL
B-catenin	NULL
in	NULL
digitonin-permeabilized	NULL
cells	NULL
does	NULL
not	NULL
require	NULL
cytoplasmic	NULL
extracts	NULL
which	NULL
contain	NULL
importin	NULL
«	NULL
/B	NULL
NLS	NULL
receptor	NULL
complexes	NULL
(	NULL
2	NULL
,	NULL
25	NULL
)	NULL
.	NULL

While	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
B-catenin	NULL
is	NULL
capable	NULL
of	NULL
entering	NULL
nuclei	NULL
independently	NULL
of	NULL
im-portins	NULL
,	NULL
a	NULL
direct	NULL
test	NULL
for	NULL
recognition	NULL
of	NULL
B-catenin	NULL
by	NULL
an	NULL
NLS	NULL
receptor	NULL
complex	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

To	NULL
test	NULL
for	NULL
a	NULL
direct	NULL
interaction	NULL
between	NULL
B-catenin	NULL
and	NULL
the	NULL
importin	NULL
«	NULL
/B	NULL
NLS	NULL
receptor	NULL
,	NULL
B-catenin	NULL
and	NULL
importin	NULL
«	NULL
2	NULL
(	NULL
also	NULL
known	NULL
as	NULL
pendulin/Rch1	NULL
)	NULL
were	NULL
translated	NULL
in	NULL
vitro	NULL
and	NULL
incubated	NULL
with	NULL
recombinant	NULL
GST-importin	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

An	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
importin	NULL
«	NULL
2	NULL
defective	NULL
for	NULL
GST-importin	NULL
B	NULL
binding	NULL
was	NULL
also	NULL
generated	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
and	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
binding	NULL
specificity	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

Full-length	NULL
importin	NULL
«	NULL
2	NULL
but	NULL
not	NULL
the	NULL
N-terminal	NULL
deletion	NULL
(	NULL
AN	NULL
importin	NULL
«	NULL
2	NULL
)	NULL
bound	NULL
specifically	NULL
to	NULL
GST-importin	NULL
B	NULL
,	NULL
as	NULL
expected	NULL
.	NULL

B-Catenin	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
importin	NULL
«	NULL
2	NULL
or	NULL
GST-importin	NULL
B	NULL
.	NULL

There	NULL
was	NULL
no	NULL
interaction	NULL
even	NULL
if	NULL
all	NULL
three	NULL
proteins	NULL
were	NULL
incubated	NULL
together	NULL
.	NULL

A	NULL
test	NULL
for	NULL
binding	NULL
of	NULL
B-catenin	NULL
alone	NULL
with	NULL
importin	NULL
«	NULL
2	NULL
was	NULL
also	NULL
10	NULL
%	NULL
input	NULL
U	NULL
FL	NULL
importin	NULL
a2|	NULL
+	NULL
+	NULL
+	NULL
AN	NULL
importin	NULL
a2	NULL
+	NULL
+	NULL
-catenin	NULL
+	NULL
+	NULL
+	NULL
220	NULL
97.4	NULL
-I	NULL
yore	NULL
<	NULL
-f-catenin	NULL
66-I	NULL
Pis	NULL
--	NULL
|	NULL
«	NULL
-FL	NULL
importin	NULL
a2	NULL
46	NULL
-	NULL
<	NULL
-	NULL
AN	NULL
importin	NULL
a2	NULL
GST-importing	NULL
_i	NULL
30	NULL
-I	NULL
21.5-	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

B-Catenin	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
importin	NULL
«	NULL
2	NULL
or	NULL
importin	NULL
B	NULL
.	NULL

A	NULL
GST	NULL
pull-down	NULL
experiment	NULL
with	NULL
*°S-labeled	NULL
,	NULL
in	NULL
vitro-translated	NULL
wild-type	NULL
B-catenin	NULL
,	NULL
importin	NULL
«	NULL
2	NULL
,	NULL
and	NULL
recombinant	NULL
GST-importin	NULL
B	NULL
was	NULL
performed	NULL
.	NULL

An	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
importin	NULL
«	NULL
2	NULL
that	NULL
removes	NULL
the	NULL
importin	NULL
B	NULL
interaction	NULL
domain	NULL
(	NULL
AN	NULL
importin	NULL
2	NULL
)	NULL
was	NULL
included	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
for	NULL
nonspecific	NULL
binding	NULL
.	NULL

The	NULL
first	NULL
three	NULL
lanes	NULL
indicate	NULL
the	NULL
amount	NULL
of	NULL
importin	NULL
«	NULL
2	NULL
and	NULL
B-catenin	NULL
proteins	NULL
added	NULL
(	NULL
10	NULL
%	NULL
input	NULL
)	NULL
.	NULL

While	NULL
full-length	NULL
(	NULL
FL	NULL
)	NULL
importin	NULL
a2	NULL
readily	NULL
interacts	NULL
with	NULL
GST-importin	NULL
B	NULL
,	NULL
B-catenin	NULL
does	NULL
not	NULL
,	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
importin	NULL
«	NULL
2	NULL
.	NULL

4508	NULL
PRIEVE	NULL
AND	NULL
WATERMAN	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

A	NULL
B	NULL
PBMC	NULL
treated	NULL
with	NULL
C	NULL
Jurkat	NULL
Untreated	NULL
PBMC	NULL
Untreated	NULL
PMA	NULL
+	NULL
lonomycin	NULL
anti-myc	NULL
DAPI	NULL
anti-myc	NULL
DAPI	NULL
anti-myc	NULL
DAPI	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Localization	NULL
of	NULL
B-catenin	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
PBMCs	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
constructs	NULL
.	NULL

Four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cell	NULL
preparations	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
or	NULL
treated	NULL
with	NULL
ethanol	NULL
as	NULL
a	NULL
mock	NULL
control	NULL
(	NULL
untreated	NULL
)	NULL
for	NULL
3	NULL
h.	NULL
(	NULL
C	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
B-catenin	NULL
constructs	NULL
,	NULL
and	NULL
subcellular	NULL
localization	NULL
was	NULL
determined	NULL
24	NULL
h	NULL
later	NULL
.	NULL

Transiently	NULL
expressed	NULL
B-catenin	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
anti-Myc	NULL
MAb	NULL
and	NULL
FITC-antimouse	NULL
secondary	NULL
antibody	NULL
.	NULL

DAPI	NULL
staining	NULL
of	NULL
DNA	NULL
indicates	NULL
the	NULL
locations	NULL
of	NULL
nuclei	NULL
.	NULL

(	NULL
A	NULL
)	NULL
In	NULL
untreated	NULL
cells	NULL
,	NULL
both	NULL
the	NULL
wild	NULL
type	NULL
and	NULL
MT10	NULL
are	NULL
cytoplasmic	NULL
while	NULL
A19	NULL
is	NULL
nuclear	NULL
.	NULL

(	NULL
B	NULL
)	NULL
When	NULL
cells	NULL
are	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
both	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
MT1O0	NULL
localize	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Wild-type	NULL
,	NULL
MT10	NULL
,	NULL
and	NULL
A19	NULL
B-catenin	NULL
all	NULL
localize	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

negative	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
vitro-translated	NULL
B-catenin	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
LEF-1	NULL
protein	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
in	NULL
vitro-translated	NULL
protein	NULL
product	NULL
is	NULL
functional	NULL
in	NULL
other	NULL
well-known	NULL
binding	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
B-catenin	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
classic	NULL
NLS	NULL
receptor	NULL
complexes	NULL
such	NULL
as	NULL
importin	NULL
«	NULL
2-importin	NULL
B	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
B-catenin	NULL
could	NULL
interact	NULL
with	NULL
another	NULL
importin	NULL
«	NULL
or	NULL
B	NULL
subtype	NULL
not	NULL
tested	NULL
here	NULL
.	NULL

However	NULL
,	NULL
a	NULL
lack	NULL
of	NULL
an	NULL
interaction	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
that	NULL
B-catenin	NULL
enters	NULL
the	NULL
nucleus	NULL
via	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
the	NULL
NLS	NULL
receptor	NULL
pathway	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Localization	NULL
of	NULL
B-catenin	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
and	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
.	NULL

Many	NULL
studies	NULL
that	NULL
have	NULL
examined	NULL
B-catenin	NULL
activation	NULL
of	NULL
gene	NULL
transcription	NULL
have	NULL
used	NULL
the	NULL
B-lymphocyte	NULL
cell	NULL
line	NULL
IIA1.6	NULL
(	NULL
36	NULL
,	NULL
37	NULL
,	NULL
44	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
T-lymphocyte	NULL
cell	NULL
lines	NULL
have	NULL
often	NULL
been	NULL
used	NULL
to	NULL
study	NULL
gene	NULL
activation	NULL
by	NULL
LEF-1	NULL
and	NULL
TCF-1	NULL
(	NULL
11	NULL
,	NULL
21	NULL
,	NULL
22	NULL
,	NULL
62	NULL
,	NULL
64	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
transcription	NULL
activation	NULL
,	NULL
most	NULL
studies	NULL
of	NULL
B-catenin	NULL
localization	NULL
have	NULL
used	NULL
adherent	NULL
cell	NULL
lines	NULL
or	NULL
normal	NULL
cells	NULL
in	NULL
whole	NULL
animal	NULL
model	NULL
systems	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
wished	NULL
to	NULL
determine	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
B-catenin	NULL
in	NULL
normal	NULL
,	NULL
untransformed	NULL
T	NULL
lymphocytes	NULL
as	NULL
well	NULL
as	NULL
a	NULL
T-lymphocyte	NULL
cell	NULL
line	NULL
.	NULL

Preparations	NULL
of	NULL
PBMCs	NULL
from	NULL
normal	NULL
human	NULL
blood	NULL
can	NULL
be	NULL
transiently	NULL
transfected	NULL
with	NULL
plasmid	NULL
DNA	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
overwhelming	NULL
majority	NULL
of	NULL
cells	NULL
that	NULL
are	NULL
transfected	NULL
in	NULL
this	NULL
procedure	NULL
are	NULL
T	NULL
lymphocytes	NULL
(	NULL
>	NULL
98	NULL
%	NULL
)	NULL
,	NULL
and	NULL
we	NULL
used	NULL
this	NULL
method	NULL
to	NULL
assess	NULL
the	NULL
localization	NULL
of	NULL
B-catenin	NULL
in	NULL
nontransformed	NULL
T	NULL
cells	NULL
.	NULL

Both	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
MT1O0	NULL
localized	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
or	NULL
cytoplasm	NULL
,	NULL
while	NULL
A19	NULL
was	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
(	NULL
lymphocytes	NULL
have	NULL
very	NULL
little	NULL
cytoplasm	NULL
compared	NULL
to	NULL
nucleus	NULL
,	NULL
making	NULL
it	NULL
difficult	NULL
to	NULL
distinguish	NULL
between	NULL
plasma	NULL
membrane	NULL
and	NULL
cyto-plasm	NULL
)	NULL
.	NULL

The	NULL
localization	NULL
patterns	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
B-catenins	NULL
in	NULL
these	NULL
cells	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
in	NULL
Cos-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
through	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
or	NULL
by	NULL
PMA-ionomycin	NULL
treatment	NULL
can	NULL
mimic	NULL
some	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
activating	NULL
the	NULL
Wat	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

For	NULL
example	NULL
,	NULL
GSK3-B	NULL
,	NULL
the	NULL
serine/threonine	NULL
kinase	NULL
that	NULL
negatively	NULL
regulates	NULL
B-catenin	NULL
,	NULL
is	NULL
inhibited	NULL
upon	NULL
T-cell	NULL
stimulation	NULL
(	NULL
67	NULL
)	NULL
.	NULL

This	NULL
causes	NULL
at	NULL
least	NULL
one	NULL
transcription	NULL
factor	NULL
(	NULL
NF-AT	NULL
)	NULL
to	NULL
accumulate	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
,	NULL
in	NULL
part	NULL
because	NULL
GSK-38B-dependent	NULL
nuclear	NULL
export	NULL
of	NULL
NF-AT	NULL
is	NULL
inhibited	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
activation	NULL
of	NULL
transfected	NULL
human	NULL
T	NULL
lymphocytes	NULL
by	NULL
PMA-ionomycin	NULL
treatment	NULL
would	NULL
cause	NULL
a	NULL
shift	NULL
in	NULL
the	NULL
localization	NULL
pattern	NULL
of	NULL
transiently	NULL
expressed	NULL
B-catenin	NULL
.	NULL

Transiently	NULL
transfected	NULL
PBMC	NULL
preparations	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
for	NULL
3	NULL
h	NULL
prior	NULL
to	NULL
fixation	NULL
;	NULL
within	NULL
this	NULL
time	NULL
,	NULL
there	NULL
was	NULL
a	NULL
quantitative	NULL
shift	NULL
in	NULL
localization	NULL
of	NULL
both	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
MT1O0	NULL
protein	NULL
from	NULL
the	NULL
plasma	NULL
membrane	NULL
or	NULL
cytoplasm	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
all	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
localization	NULL
of	NULL
A19	NULL
remained	NULL
unchanged	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
are	NULL
transformed	NULL
T	NULL
lymphocytes	NULL
;	NULL
these	NULL
cells	NULL
behave	NULL
similarly	NULL
to	NULL
activated	NULL
T	NULL
lymphocytes	NULL
in	NULL
that	NULL
they	NULL
synthesize	NULL
and	NULL
secrete	NULL
the	NULL
cytokine	NULL
interleukin	NULL
2	NULL
,	NULL
a	NULL
marker	NULL
of	NULL
T-cell	NULL
activation	NULL
(	NULL
60	NULL
)	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
wild-type	NULL
,	NULL
MT10	NULL
,	NULL
and	NULL
A19	NULL
B-catenin	NULL
protein	NULL
in	NULL
these	NULL
cells	NULL
exhibited	NULL
a	NULL
pattern	NULL
of	NULL
subcellular	NULL
localization	NULL
nearly	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
activated	NULL
normal	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

All	NULL
three	NULL
forms	NULL
were	NULL
constitutively	NULL
nuclear	NULL
;	NULL
there	NULL
was	NULL
no	NULL
dramatic	NULL
difference	NULL
between	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenin	NULL
as	NULL
there	NULL
was	NULL
in	NULL
the	NULL
Cos-1	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
again	NULL
confirmed	NULL
that	NULL
nuclear	NULL
localization	NULL
of	NULL
B-catenin	NULL
is	NULL
independent	NULL
of	NULL
LEF/TCF	NULL
binding	NULL
(	NULL
A19	NULL
is	NULL
nuclear	NULL
)	NULL
and	NULL
that	NULL
a	NULL
nuclear	NULL
localization	NULL
domain	NULL
or	NULL
determinant	NULL
is	NULL
located	NULL
within	NULL
the	NULL
first	NULL
nine	NULL
arm	NULL
repeats	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
MT1O0	NULL
is	NULL
nuclear	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
results	NULL
also	NULL
suggested	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
B-catenin	NULL
to	NULL
accumulate	NULL
in	NULL
the	NULL
nucleus	NULL
differs	NULL
between	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
PMA-ionomycin-directed	NULL
shift	NULL
in	NULL
subcellular	NULL
localization	NULL
of	NULL
B-catenin	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
suggested	NULL
either	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
B-catenin	NULL
to	NULL
access	NULL
its	NULL
nuclear	NULL
transport	NULL
pathway	NULL
is	NULL
regulated	NULL
or	NULL
that	NULL
the	NULL
transport	NULL
pathway	NULL
used	NULL
by	NULL
B-catenin	NULL
is	NULL
itself	NULL
under	NULL
tight	NULL
restriction	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
B-cate-	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
A	NULL
Control	NULL
anti-myec	NULL
pB-catenin	NULL
wt	NULL
A19	NULL
B-catenin	NULL
NUCLEAR	NULL
LOCALIZATION	NULL
AND	NULL
GENE	NULL
ACTIVATION	NULL
BY	NULL
B-CATENIN	NULL
-	NULL
4509	NULL
B	NULL
Actinomycin	NULL
D	NULL
+	NULL
Cycloheximide	NULL
anti-mye	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Wild-type	NULL
and	NULL
A19	NULL
B-catenins	NULL
are	NULL
exported	NULL
from	NULL
the	NULL
nucleus	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

PBMCs	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
constructs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Six	NULL
hours	NULL
prior	NULL
to	NULL
harvest	NULL
,	NULL
cell	NULL
preparations	NULL
were	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
(	NULL
Control	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Three	NULL
hours	NULL
prior	NULL
to	NULL
harvest	NULL
,	NULL
cell	NULL
preparations	NULL
were	NULL
treated	NULL
with	NULL
actinomycin	NULL
D	NULL
and	NULL
cycloheximide	NULL
.	NULL

Transiently	NULL
expressed	NULL
B-catenin	NULL
was	NULL
detected	NULL
with	NULL
anti-Myc	NULL
MAb	NULL
and	NULL
FITC-anti-mouse	NULL
secondary	NULL
antibody	NULL
.	NULL

DAPI	NULL
staining	NULL
of	NULL
DNA	NULL
indicates	NULL
the	NULL
locations	NULL
of	NULL
nuclei	NULL
.	NULL

In	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
and	NULL
ionomycin	NULL
,	NULL
both	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenins	NULL
are	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Subsequent	NULL
treatment	NULL
with	NULL
actinomycin	NULL
D	NULL
and	NULL
cycloheximide	NULL
inhibits	NULL
nuclear	NULL
import	NULL
and	NULL
protein	NULL
synthesis	NULL
.	NULL

With	NULL
these	NULL
treatments	NULL
,	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenins	NULL
are	NULL
exported	NULL
to	NULL
the	NULL
cytoplasm	NULL
.	NULL

nin	NULL
might	NULL
be	NULL
capable	NULL
of	NULL
both	NULL
nuclear	NULL
import	NULL
and	NULL
export	NULL
.	NULL

In	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
NF-AT	NULL
,	NULL
PMA-ionomycin	NULL
treatment	NULL
may	NULL
cause	NULL
nuclear	NULL
accumulation	NULL
of	NULL
B-catenin	NULL
by	NULL
shifting	NULL
the	NULL
kinetic	NULL
balance	NULL
to	NULL
favor	NULL
import	NULL
over	NULL
export	NULL
.	NULL

If	NULL
this	NULL
were	NULL
true	NULL
,	NULL
the	NULL
constitutive	NULL
nuclear	NULL
accumulation	NULL
of	NULL
A19	NULL
might	NULL
be	NULL
due	NULL
to	NULL
an	NULL
inability	NULL
of	NULL
the	NULL
A19	NULL
mutant	NULL
protein	NULL
to	NULL
be	NULL
exported	NULL
from	NULL
the	NULL
nucleus	NULL
.	NULL

Export	NULL
of	NULL
B-catenin	NULL
from	NULL
nuclei	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
wild-type	NULL
B-catenin	NULL
could	NULL
undergo	NULL
nuclear	NULL
export	NULL
,	NULL
and	NULL
we	NULL
also	NULL
tested	NULL
whether	NULL
A19	NULL
exhibited	NULL
any	NULL
differences	NULL
with	NULL
respect	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

A	NULL
common	NULL
method	NULL
to	NULL
test	NULL
for	NULL
nuclear	NULL
export	NULL
of	NULL
proteins	NULL
is	NULL
to	NULL
block	NULL
nuclear	NULL
import	NULL
with	NULL
actinomycin	NULL
D	NULL
treatment	NULL
(	NULL
a	NULL
transcription	NULL
inhibitor	NULL
)	NULL
and	NULL
to	NULL
block	NULL
protein	NULL
synthesis	NULL
with	NULL
cycloheximide	NULL
such	NULL
that	NULL
no	NULL
newly	NULL
synthesized	NULL
protein	NULL
accumulates	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
any	NULL
formerly	NULL
nucleus-localized	NULL
protein	NULL
that	NULL
accumulates	NULL
in	NULL
the	NULL
cytoplasm	NULL
in	NULL
these	NULL
treated	NULL
cells	NULL
must	NULL
have	NULL
undergone	NULL
active	NULL
export	NULL
from	NULL
the	NULL
nucleus	NULL
.	NULL

PBMC	NULL
preparations	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
wild-type	NULL
or	NULL
A19	NULL
B-catenin	NULL
expression	NULL
plasmid	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
PMA-ionomycin	NULL
to	NULL
direct	NULL
all	NULL
B-catenin	NULL
protein	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Actinomycin	NULL
D	NULL
and	NULL
cycloheximide	NULL
were	NULL
added	NULL
to	NULL
half	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
block	NULL
import	NULL
and	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

After	NULL
3	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
processed	NULL
for	NULL
immunofluores-cence	NULL
.	NULL

Both	NULL
wild-type	NULL
and	NULL
A19	NULL
B-catenin	NULL
staining	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
not	NULL
the	NULL
nucleus	NULL
,	NULL
suggesting	NULL
that	NULL
both	NULL
were	NULL
actively	NULL
exported	NULL
from	NULL
the	NULL
nucleus	NULL
during	NULL
actinomycin	NULL
D-cycloheximide	NULL
treatment	NULL
.	NULL

Overall	NULL
fluorescence	NULL
was	NULL
weaker	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
these	NULL
reagents	NULL
because	NULL
protein	NULL
synthesis	NULL
was	NULL
completely	NULL
inhibited	NULL
for	NULL
3	NULL
h	NULL
,	NULL
and	NULL
exported	NULL
B-catenin	NULL
may	NULL
have	NULL
been	NULL
subject	NULL
to	NULL
degradation	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

A	NULL
less	NULL
likely	NULL
explanation	NULL
is	NULL
that	NULL
a	NULL
low	NULL
level	NULL
of	NULL
cytoplasmic	NULL
B-catenin	NULL
remained	NULL
stable	NULL
throughout	NULL
the	NULL
3-h	NULL
incubation	NULL
with	NULL
cyclohexi-mide	NULL
,	NULL
and	NULL
nuclear	NULL
B-catenin	NULL
was	NULL
preferentially	NULL
degraded	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
the	NULL
differing	NULL
localization	NULL
patterns	NULL
between	NULL
wild-type	NULL
B-catenin	NULL
(	NULL
cytoplasm	NULL
)	NULL
and	NULL
A19	NULL
(	NULL
nucleus	NULL
)	NULL
in	NULL
unstimulated	NULL
T	NULL
lymphocytes	NULL
are	NULL
not	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
import	NULL
or	NULL
export	NULL
.	NULL

B-Catenin-	NULL
and	NULL
LEF-1-dependent	NULL
activation	NULL
of	NULL
transcription	NULL
varies	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
dramatic	NULL
effects	NULL
that	NULL
the	NULL
A19	NULL
mutation	NULL
has	NULL
on	NULL
localization	NULL
,	NULL
we	NULL
also	NULL
determined	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
mutation	NULL
on	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
LEF-1	NULL
and	NULL
B-catenin	NULL
in	NULL
Cos-1	NULL
cells	NULL
,	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
different	NULL
in	NULL
some	NULL
aspect	NULL
of	NULL
B-catenin	NULL
localization	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
examine	NULL
the	NULL
ability	NULL
of	NULL
only	NULL
the	NULL
transiently	NULL
expressed	NULL
proteins	NULL
to	NULL
work	NULL
together	NULL
,	NULL
a	NULL
LEF-1	NULL
fusion	NULL
protein	NULL
,	NULL
in	NULL
which	NULL
the	NULL
first	NULL
256	NULL
aa	NULL
of	NULL
LEF-1	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
yeast	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
,	NULL
was	NULL
used	NULL
in	NULL
place	NULL
of	NULL
full-length	NULL
LEF-1	NULL
protein	NULL
(	NULL
G4LEF	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
reporter	NULL
plasmid	NULL
contained	NULL
five	NULL
Gal4	NULL
upstream	NULL
activating	NULL
sites	NULL
(	NULL
UAS	NULL
)	NULL
placed	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
promoter	NULL
driving	NULL
luciferase	NULL
coding	NULL
sequences	NULL
(	NULL
G4	NULL
UAS/Luc	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
G4LEF	NULL
expression	NULL
plasmid	NULL
with	NULL
the	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
plasmid	NULL
did	NULL
not	NULL
produce	NULL
significant	NULL
luciferase	NULL
expression	NULL
in	NULL
Cos-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
if	NULL
a	NULL
B-catenin	NULL
expression	NULL
plasmid	NULL
was	NULL
included	NULL
,	NULL
a	NULL
fourfold	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
expression	NULL
was	NULL
observed	NULL
.	NULL

Cotransfection	NULL
of	NULL
A19	NULL
with	NULL
G4LEF	NULL
yielded	NULL
only	NULL
basal	NULL
levels	NULL
of	NULL
expression	NULL
,	NULL
confirming	NULL
that	NULL
,	NULL
in	NULL
vivo	NULL
,	NULL
the	NULL
A19	NULL
mutant	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
G4LEF	NULL
even	NULL
though	NULL
both	NULL
proteins	NULL
are	NULL
concentrated	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

3	NULL
for	NULL
B-catenin	NULL
localization	NULL
)	NULL
.	NULL

The	NULL
modest	NULL
fourfold	NULL
activation	NULL
is	NULL
due	NULL
to	NULL
a	NULL
bona	NULL
fide	NULL
interaction	NULL
between	NULL
LEF-1	NULL
and	NULL
B-catenin	NULL
,	NULL
because	NULL
an	NULL
N-terminal	NULL
deletion	NULL
of	NULL
LEF-1	NULL
missing	NULL
the	NULL
B-catenin	NULL
binding	NULL
domain	NULL
does	NULL
not	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
[	NULL
G4LEF	NULL
(	NULL
80-256	NULL
)	NULL
+	NULL
B-cat	NULL
;	NULL
Fig	NULL
.	NULL

7A	NULL
]	NULL
.	NULL

In	NULL
Cos-1	NULL
cells	NULL
,	NULL
overexpression	NULL
of	NULL
G4LEF	NULL
does	NULL
not	NULL
cause	NULL
a	NULL
change	NULL
in	NULL
the	NULL
subcellular	NULL
distribution	NULL
of	NULL
B-catenin	NULL
protein	NULL
,	NULL
similar	NULL
to	NULL
what	NULL
is	NULL
observed	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
55a	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
B-catenin	NULL
remains	NULL
mostly	NULL
localized	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
cytoplasm	NULL
,	NULL
thereby	NULL
accounting	NULL
for	NULL
the	NULL
modest	NULL
levels	NULL
of	NULL
activation	NULL
observed	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
,	NULL
transiently	NULL
expressed	NULL
B-catenin	NULL
4510	NULL
PRIEVE	NULL
AND	NULL
WATERMAN	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

G4	NULL
UAS	NULL
(	NULL
Luc—	NULL
--	NULL
-I	NULL
:	NULL
Luciferase	NULL
--	NULL
0	NULL
500	NULL
1,000	NULL
1,500	NULL
2,000	NULL
2,500	NULL
3,000	NULL
A	NULL
Ex	NULL
!	NULL

:	NULL
:	NULL
:	NULL
'	NULL
}	NULL
Control	NULL
|	NULL
-	NULL
|	NULL
|	NULL
ﬂ	NULL
GA4LEF	NULL
|	NULL
GALEF	NULL
+	NULL
B-cat	NULL
|	NULL
-	NULL
Cos-1	NULL
G4LEF	NULL
+	NULL
A19	NULL
|	NULL
G4LEF	NULL
(	NULL
80-256	NULL
)	NULL
+	NULL
B-cat	NULL
|	NULL
.	NULL

__	NULL
0	NULL
25,000	NULL
50,000	NULL
75,000	NULL
100,000	NULL
B	NULL
P+I	NULL
|	NULL
1	NULL
I	NULL
I	NULL
T	NULL
T	NULL
T	NULL
Control	NULL
|	NULL
|	NULL
Control	NULL
|	NULL
+	NULL
G4LEF	NULL
|	NULL
GALEF	NULL
|	NULL
+	NULL
G4LEF	NULL
+	NULL
B-cat	NULL
|	NULL
=	NULL
GALEF	NULL
+	NULL
B-cat	NULL
|	NULL
+	NULL
G4LEF	NULL
+	NULL
AMQ	NULL
|	NULL
-	NULL
Jurkat	NULL
G4LEF	NULL
+	NULL
M19	NULL
|	NULL
+	NULL
G4LEF	NULL
+	NULL
MT10	NULL
|	NULL
G4LEF	NULL
+	NULL
MT10	NULL
|	NULL
+	NULL
G4LEF	NULL
(	NULL
80-256	NULL
)	NULL
+	NULL
B-cat	NULL
|	NULL
G4LEF	NULL
(	NULL
B0-256	NULL
)	NULL
+	NULL
B-cat	NULL
|	NULL
+	NULL
G4VP16	NULL
0	NULL
5,000	NULL
10,000	NULL
15,000	NULL
20,000	NULL
25,000	NULL
C	NULL
F=	NULL
!	NULL

!	NULL
}	NULL

:	NULL
G4Luc	NULL
+	NULL
G4LEF	NULL
|	NULL
-	NULL
|	NULL
}	NULL
|	NULL
Galuc+	NULL
Galer	NULL
|	NULL
+||	NULL
o	NULL
P+	NULL
G4Luc	NULL
+	NULL
G4LEF	NULL
+	NULL
B-cat	NULL
GA4Luc	NULL
+	NULL
G4LEF	NULL
+	NULL
B-cat	NULL
PBMC	NULL
*	NULL
TopTK	NULL
+	NULL
FL	NULL
LEF	NULL
*	NULL
TopTK	NULL
+	NULL
FL	NULL
LEF	NULL
+	NULL
B-cat	NULL
GALuc	NULL
+	NULL
G4VP16	NULL
Light	NULL
Units	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

A	NULL
direct	NULL
interaction	NULL
between	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

Wild-type	NULL
,	NULL
A19	NULL
,	NULL
or	NULL
MT1O	NULL
B-catenin	NULL
expression	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
Gal4	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
fused	NULL
to	NULL
LEF-1	NULL
aa	NULL
1	NULL
to	NULL
256	NULL
(	NULL
G4LEF	NULL
)	NULL
and	NULL
a	NULL
reporter	NULL
plasmid	NULL
containing	NULL
five	NULL
tandemly	NULL
repeated	NULL
Gal4	NULL
UAS	NULL
directing	NULL
luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
G4	NULL
UAS/Luc	NULL
)	NULL
expression	NULL
in	NULL
Cos-1	NULL
and	NULL
Jurkat	NULL
cells	NULL
and	NULL
PBMCs	NULL
.	NULL

A	NULL
summary	NULL
of	NULL
the	NULL
B-catenin	NULL
localization	NULL
in	NULL
each	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
upper	NULL
right	NULL
corner	NULL
of	NULL
each	NULL
panel	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Five	NULL
micrograms	NULL
of	NULL
B-catenin	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
G4LEF	NULL
expression	NULL
plasmids	NULL
,	NULL
and	NULL
1	NULL
g	NULL
of	NULL
reporter	NULL
plasmid	NULL
were	NULL
transfected	NULL
into	NULL
Cos-1	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Seven	NULL
hundred	NULL
fifty	NULL
nanograms	NULL
of	NULL
B-catenin	NULL
and	NULL
50	NULL
ng	NULL
of	NULL
G4LEF	NULL
expression	NULL
plasmids	NULL
or	NULL
750	NULL
ng	NULL
of	NULL
G4VP16	NULL
expression	NULL
plasmid	NULL
and	NULL
1	NULL
g	NULL
of	NULL
reporter	NULL
plasmid	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
B-catenin	NULL
,	NULL
the	NULL
range	NULL
of	NULL
luciferase	NULL
activity	NULL
varied	NULL
from	NULL
574	NULL
to	NULL
825	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
indicated	NULL
expression	NULL
plasmids	NULL
(	NULL
10	NULL
g	NULL
)	NULL
were	NULL
cotransfected	NULL
with	NULL
10	NULL
g	NULL
of	NULL
reporter	NULL
plasmid	NULL
into	NULL
PBMCs	NULL
.	NULL

P	NULL
+	NULL
I	NULL
,	NULL
treatment	NULL
of	NULL
cell	NULL
preparations	NULL
with	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
for	NULL
3	NULL
h	NULL
prior	NULL
to	NULL
harvest	NULL
of	NULL
cells	NULL
;	NULL
*	NULL
,	NULL
use	NULL
of	NULL
the	NULL
Top	NULL
TK	NULL
reporter	NULL
plasmid	NULL
in	NULL
place	NULL
of	NULL
the	NULL
G4	NULL
UAS/Luce	NULL
reporter	NULL
plasmid	NULL
.	NULL

A	NULL
plasmid	NULL
(	NULL
0.5	NULL
g	NULL
)	NULL
containing	NULL
the	NULL
lacZ	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
was	NULL
cotransfected	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

G4LEF	NULL
(	NULL
aa	NULL
80	NULL
to	NULL
256	NULL
)	NULL
,	NULL
which	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
B-catenin	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

An	NULL
empty	NULL
eukaryotic	NULL
expression	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
equalize	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
used	NULL
in	NULL
each	NULL
transfection	NULL
.	NULL

Cells	NULL
were	NULL
harvested	NULL
at	NULL
15	NULL
to	NULL
24	NULL
h	NULL
posttransfection	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
for	NULL
luciferase	NULL
and	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

Wild-type	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
transactivated	NULL
the	NULL
reporter	NULL
gene	NULL
construct	NULL
in	NULL
Cos-1	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
while	NULL
neither	NULL
A19	NULL
nor	NULL
MT10	NULL
cooperated	NULL
with	NULL
LEF-1	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
activation	NULL
of	NULL
B-catenin-LEF-1	NULL
complexes	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
G4VP16	NULL
(	NULL
750	NULL
ng	NULL
)	NULL
.	NULL

B-Catenin	NULL
and	NULL
G4LEF-1	NULL
or	NULL
full-length	NULL
LEF-1	NULL
(	NULL
FL	NULL
LEF-1	NULL
)	NULL
did	NULL
not	NULL
transactivate	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
PBMCs	NULL
,	NULL
although	NULL
G4VP16	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
was	NULL
able	NULL
to	NULL
transactivate	NULL
the	NULL
reporter	NULL
gene	NULL
in	NULL
PBMCs	NULL
.	NULL

Error	NULL
bars	NULL
were	NULL
calculated	NULL
by	NULL
using	NULL
the	NULL
average	NULL
of	NULL
duplicate	NULL
points	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
or	NULL
triplicate	NULL
points	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
replicate	NULL
experiments	NULL
.	NULL

protein	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
_	NULL
what	NULL
can	NULL
be	NULL
achieved	NULL
by	NULL
the	NULL
strong	NULL
activating	NULL
fusion	NULL
protein	NULL
G4LEF	NULL
and	NULL
B-catenin	NULL
expression	NULL
plasmids	NULL
in	NULL
these	NULL
cells	NULL
stim-	NULL
Gal4-VP16	NULL
(	NULL
G4VP16	NULL
)	NULL
(	NULL
35-fold	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
for	NULL
Cos-1	NULL
cells	NULL
,	NULL
ulated	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
expression	NULL
(	NULL
150-fold	NULL
)	NULL
cotransfection	NULL
of	NULL
A19	NULL
B-catenin	NULL
did	NULL
not	NULL
activate	NULL
gene	NULL
expres-	NULL
(	NULL
G4LEF	NULL
+	NULL
Beat	NULL
[	NULL
Fig	NULL
.	NULL

7B	NULL
]	NULL
)	NULL
,	NULL
an	NULL
even	NULL
greater	NULL
activation	NULL
than	NULL
sion	NULL
at	NULL
all	NULL
,	NULL
nor	NULL
did	NULL
MT1O0	NULL
or	NULL
the	NULL
G4LEF	NULL
mutant	NULL
missing	NULL
the	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
B-catenin	NULL
binding	NULL
domain	NULL
,	NULL
even	NULL
though	NULL
all	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
PMA-ionomycin	NULL
did	NULL
not	NULL
change	NULL
the	NULL
transactivation	NULL
potential	NULL
of	NULL
LEF-1	NULL
and	NULL
B-catenin	NULL
.	NULL

Either	NULL
B-catenin	NULL
has	NULL
a	NULL
strong	NULL
costimulatory	NULL
effect	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
due	NULL
to	NULL
the	NULL
overall	NULL
strength	NULL
of	NULL
its	NULL
nuclear	NULL
localization	NULL
or	NULL
another	NULL
transcription	NULL
cofactor	NULL
or	NULL
basal	NULL
factor	NULL
is	NULL
abundant	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
strong	NULL
activation	NULL
could	NULL
be	NULL
observed	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
B-catenin	NULL
and	NULL
G4LEF	NULL
were	NULL
unable	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
,	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA-ionomycin	NULL
treatment	NULL
(	NULL
which	NULL
causes	NULL
a	NULL
quantitative	NULL
shift	NULL
of	NULL
B-catenin	NULL
into	NULL
the	NULL
nucleus	NULL
[	NULL
see	NULL
Fig	NULL
.	NULL

5B	NULL
for	NULL
localization	NULL
patterns	NULL
]	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
equivalent	NULL
amount	NULL
of	NULL
G4VP16	NULL
was	NULL
able	NULL
to	NULL
produce	NULL
a	NULL
115-fold	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
activation	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
VP16	NULL
transcription	NULL
activation	NULL
domain	NULL
is	NULL
possible	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
are	NULL
not	NULL
able	NULL
to	NULL
elicit	NULL
detectable	NULL
amounts	NULL
of	NULL
luciferase	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
dramatic	NULL
difference	NULL
between	NULL
the	NULL
activities	NULL
of	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
in	NULL
normal	NULL
versus	NULL
transformed	NULL
lymphocytes	NULL
is	NULL
not	NULL
due	NULL
to	NULL
differential	NULL
localization	NULL
or	NULL
to	NULL
dramatic	NULL
differences	NULL
in	NULL
protein	NULL
stabil-ity	NULL
,	NULL
as	NULL
our	NULL
immunofluorescence	NULL
data	NULL
indicate	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
that	NULL
G4LEF	NULL
was	NULL
the	NULL
cause	NULL
of	NULL
this	NULL
differential	NULL
activation	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
full-length	NULL
B-catenin	NULL
and	NULL
full-length	NULL
,	NULL
wild-type	NULL
LEF-1	NULL
could	NULL
activate	NULL
gene	NULL
expression	NULL
with	NULL
the	NULL
Top	NULL
TK	NULL
reporter	NULL
plasmid	NULL
(	NULL
44	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
contains	NULL
five	NULL
multimerized	NULL
LEF/TCF	NULL
binding	NULL
sites	NULL
and	NULL
has	NULL
been	NULL
used	NULL
extensively	NULL
to	NULL
examine	NULL
LEF-1-B-catenin	NULL
reporter	NULL
gene	NULL
activation	NULL
in	NULL
many	NULL
different	NULL
cell	NULL
types	NULL
(	NULL
27	NULL
,	NULL
29	NULL
,	NULL
36	NULL
,	NULL
44	NULL
,	NULL
45	NULL
,	NULL
59	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Wild-type	NULL
LEF-1	NULL
and	NULL
wild-type	NULL
B-catenin	NULL
were	NULL
unable	NULL
to	NULL
activate	NULL
Top	NULL
TK	NULL
reporter	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
Top	NULL
TK	NULL
reporter	NULL
plasmid	NULL
was	NULL
tested	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

High	NULL
levels	NULL
of	NULL
wild-type	NULL
LEF-1	NULL
and	NULL
wild-type	NULL
B-catenin	NULL
were	NULL
able	NULL
to	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
,	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
with	NULL
the	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
plasmid	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
the	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
plasmid	NULL
functions	NULL
in	NULL
a	NULL
manner	NULL
similar	NULL
to	NULL
the	NULL
wild-type	NULL
LEF/TCF	NULL
binding	NULL
site	NULL
reporter	NULL
plasmid	NULL
.	NULL

One	NULL
possibility	NULL
for	NULL
the	NULL
different	NULL
activities	NULL
of	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
is	NULL
that	NULL
another	NULL
cofactor	NULL
is	NULL
required	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

This	NULL
cofactor	NULL
might	NULL
be	NULL
abundant	NULL
in	NULL
Jurkat	NULL
cells	NULL
but	NULL
absent	NULL
or	NULL
limiting	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Such	NULL
a	NULL
cofactor	NULL
may	NULL
not	NULL
be	NULL
an	NULL
essential	NULL
basal	NULL
RNA	NULL
polymerase	NULL
II	NULL
factor	NULL
,	NULL
as	NULL
G4VP16	NULL
fusion	NULL
protein	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
.	NULL

A19	NULL
can	NULL
squelch	NULL
B-catenin-activated	NULL
gene	NULL
expression	NULL
but	NULL
not	NULL
VP16-activated	NULL
gene	NULL
expression	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
another	NULL
nuclear	NULL
component	NULL
is	NULL
required	NULL
for	NULL
B-catenin-LEF-1	NULL
complexes	NULL
to	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
,	NULL
a	NULL
squelching	NULL
experiment	NULL
was	NULL
designed	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
B-catenin	NULL
contains	NULL
transcription	NULL
activation	NULL
domains	NULL
in	NULL
the	NULL
C	NULL
terminus	NULL
and	NULL
the	NULL
N	NULL
terminus	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
27	NULL
,	NULL
63	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
regions	NULL
do	NULL
not	NULL
have	NULL
sequence	NULL
similarity	NULL
or	NULL
amino	NULL
acid	NULL
compositions	NULL
similar	NULL
to	NULL
known	NULL
transcription	NULL
activation	NULL
domains	NULL
,	NULL
they	NULL
can	NULL
activate	NULL
gene	NULL
expression	NULL
when	NULL
fused	NULL
to	NULL
heterologous	NULL
DNA	NULL
binding	NULL
domains	NULL
such	NULL
as	NULL
LEF-1	NULL
or	NULL
Gal4	NULL
(	NULL
27	NULL
,	NULL
59	NULL
,	NULL
63	NULL
)	NULL
.	NULL

If	NULL
either	NULL
domain	NULL
of	NULL
B-catenin	NULL
is	NULL
interacting	NULL
with	NULL
a	NULL
third	NULL
required	NULL
transcription	NULL
factor	NULL
,	NULL
then	NULL
overexpression	NULL
of	NULL
this	NULL
domain	NULL
should	NULL
sequester	NULL
the	NULL
third	NULL
component	NULL
from	NULL
wild-type	NULL
B-catenin-LEF-1	NULL
complexes	NULL
and	NULL
inhibit	NULL
activation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

This	NULL
method	NULL
of	NULL
inhibition	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
squelching	NULL
.	NULL

To	NULL
carry	NULL
out	NULL
the	NULL
experiment	NULL
,	NULL
overexpression	NULL
of	NULL
the	NULL
A19	NULL
B-catenin	NULL
mutant	NULL
was	NULL
used	NULL
to	NULL
test	NULL
for	NULL
squelching	NULL
.	NULL

Since	NULL
A19	NULL
is	NULL
completely	NULL
negative	NULL
for	NULL
binding	NULL
to	NULL
LEF/TCF	NULL
proteins	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
7	NULL
)	NULL
,	NULL
no	NULL
squelching	NULL
should	NULL
occur	NULL
due	NULL
to	NULL
simple	NULL
sequestration	NULL
of	NULL
LEF-1	NULL
protein	NULL
.	NULL

Secondly	NULL
,	NULL
A19	NULL
protein	NULL
localizes	NULL
constitutively	NULL
to	NULL
the	NULL
nucleus	NULL
of	NULL
all	NULL
cells	NULL
where	NULL
squelch	NULL
NUCLEAR	NULL
LOCALIZATION	NULL
AND	NULL
GENE	NULL
ACTIVATION	NULL
BY	NULL
B-CATENIN	NULL
_	NULL
4511	NULL
ing	NULL
of	NULL
transcription	NULL
factor	NULL
components	NULL
should	NULL
occur	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
used	NULL
because	NULL
the	NULL
level	NULL
of	NULL
activation	NULL
is	NULL
very	NULL
high	NULL
.	NULL

In	NULL
the	NULL
experiment	NULL
represented	NULL
by	NULL
Fig	NULL
.	NULL

8A	NULL
,	NULL
G4LEF	NULL
and	NULL
B-catenin	NULL
activated	NULL
luciferase	NULL
reporter	NULL
gene	NULL
expression	NULL
125-fold	NULL
.	NULL

Excess	NULL
plasmid	NULL
containing	NULL
the	NULL
strong	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
promoter	NULL
was	NULL
used	NULL
to	NULL
control	NULL
for	NULL
inhibitory	NULL
effects	NULL
due	NULL
to	NULL
competition	NULL
for	NULL
basal	NULL
polymerase	NULL
II	NULL
components	NULL
.	NULL

As	NULL
this	NULL
balancer	NULL
plasmid	NULL
was	NULL
increased	NULL
from	NULL
a	NULL
4-fold	NULL
to	NULL
a	NULL
20-fold	NULL
excess	NULL
,	NULL
a	NULL
15	NULL
%	NULL
drop	NULL
in	NULL
G4LEF/B-catenin-dependent	NULL
luciferase	NULL
activity	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
large	NULL
amounts	NULL
of	NULL
competitive	NULL
CMV	NULL
promoter-containing	NULL
plasmid	NULL
may	NULL
account	NULL
for	NULL
a	NULL
minor	NULL
inhibitory	NULL
effect	NULL
.	NULL

There	NULL
was	NULL
a	NULL
2-fold	NULL
drop	NULL
in	NULL
luciferase	NULL
activity	NULL
when	NULL
a	NULL
4-fold	NULL
excess	NULL
of	NULL
A19	NULL
plasmid	NULL
was	NULL
included	NULL
,	NULL
and	NULL
a	NULL
20-fold	NULL
excess	NULL
of	NULL
A19	NULL
plasmid	NULL
caused	NULL
a	NULL
22-fold	NULL
drop	NULL
in	NULL
activation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
overexpression	NULL
of	NULL
B-catenin	NULL
can	NULL
indeed	NULL
squelch	NULL
activation	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
by	NULL
sequestering	NULL
a	NULL
required	NULL
component	NULL
.	NULL

The	NULL
A19	NULL
mutant	NULL
B-catenin	NULL
was	NULL
further	NULL
modified	NULL
to	NULL
remove	NULL
the	NULL
hydrophilic	NULL
N	NULL
terminus	NULL
(	NULL
ANA19	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Fourfold	NULL
and	NULL
20-fold	NULL
excess	NULL
ANA19	NULL
plasmid	NULL
also	NULL
exhibited	NULL
squelching	NULL
,	NULL
albeit	NULL
to	NULL
a	NULL
slightly	NULL
lesser	NULL
extent	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
60-fold	NULL
excess	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
encoding	NULL
ANLEF	NULL
,	NULL
an	NULL
N-terminal	NULL
deletion	NULL
mutant	NULL
of	NULL
wild-type	NULL
LEF-1	NULL
missing	NULL
the	NULL
B-catenin	NULL
binding	NULL
domain	NULL
,	NULL
was	NULL
unable	NULL
to	NULL
squelch	NULL
reporter	NULL
gene	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
squelching	NULL
activity	NULL
is	NULL
specific	NULL
to	NULL
a	NULL
region	NULL
of	NULL
B-catenin	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
A19	NULL
B-catenin	NULL
was	NULL
squelching	NULL
by	NULL
inhibiting	NULL
a	NULL
general	NULL
step	NULL
in	NULL
polymerase	NULL
II	NULL
tran-scription	NULL
,	NULL
beyond	NULL
the	NULL
point	NULL
of	NULL
initiation	NULL
,	NULL
4-fold	NULL
and	NULL
20-fold	NULL
excess	NULL
B-catenin	NULL
was	NULL
tested	NULL
against	NULL
G4VP16	NULL
activation	NULL
of	NULL
the	NULL
same	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
20-fold	NULL
excess	NULL
balancer	NULL
plasmid	NULL
elicited	NULL
a	NULL
20	NULL
%	NULL
decrease	NULL
in	NULL
G4VP16	NULL
activation	NULL
from	NULL
35-fold	NULL
activation	NULL
to	NULL
29-fold	NULL
activation	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
4-fold	NULL
excess	NULL
of	NULL
B-catenin	NULL
plasmid	NULL
caused	NULL
a	NULL
32	NULL
%	NULL
decrease	NULL
in	NULL
G4VP16	NULL
activation	NULL
,	NULL
and	NULL
a	NULL
20-fold	NULL
excess	NULL
caused	NULL
a	NULL
31	NULL
%	NULL
decrease	NULL
,	NULL
compared	NULL
to	NULL
matched	NULL
controls	NULL
.	NULL

This	NULL
amount	NULL
of	NULL
inhibition	NULL
is	NULL
minor	NULL
compared	NULL
to	NULL
the	NULL
striking	NULL
effect	NULL
on	NULL
G4LEF	NULL
and	NULL
B-catenin	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
level	NULL
of	NULL
inhibition	NULL
does	NULL
not	NULL
change	NULL
when	NULL
the	NULL
excess	NULL
of	NULL
B-catenin	NULL
plasmid	NULL
is	NULL
increased	NULL
from	NULL
4-fold	NULL
to	NULL
20-fold	NULL
but	NULL
stays	NULL
constant	NULL
at	NULL
approximately	NULL
30	NULL
%	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
minor	NULL
inhibitory	NULL
effect	NULL
is	NULL
due	NULL
to	NULL
reasons	NULL
other	NULL
than	NULL
specific	NULL
squelching	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
B-catenin	NULL
can	NULL
squelch	NULL
reporter	NULL
gene	NULL
expression	NULL
because	NULL
a	NULL
domain	NULL
within	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
or	NULL
the	NULL
C	NULL
terminus	NULL
is	NULL
interacting	NULL
with	NULL
a	NULL
third	NULL
component	NULL
required	NULL
by	NULL
B-catenin-LEF-1	NULL
complexes	NULL
to	NULL
activate	NULL
gene	NULL
transcription	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
examined	NULL
nuclear	NULL
localization	NULL
of	NULL
B-catenin	NULL
and	NULL
demonstrate	NULL
directly	NULL
that	NULL
nuclear	NULL
import	NULL
is	NULL
independent	NULL
of	NULL
LEF/TCF	NULL
binding	NULL
;	NULL
we	NULL
also	NULL
show	NULL
data	NULL
to	NULL
suggest	NULL
that	NULL
B-catenin	NULL
can	NULL
be	NULL
exported	NULL
from	NULL
nuclei	NULL
.	NULL

Below	NULL
,	NULL
we	NULL
discuss	NULL
a	NULL
model	NULL
in	NULL
which	NULL
subcellular	NULL
localization	NULL
of	NULL
B-catenin	NULL
is	NULL
shaped	NULL
by	NULL
competing	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
sequestration	NULL
and	NULL
the	NULL
relative	NULL
rates	NULL
of	NULL
nuclear	NULL
import	NULL
and	NULL
nuclear	NULL
export	NULL
.	NULL

B-Catenin-LEF-1	NULL
complexes	NULL
do	NULL
not	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
even	NULL
though	NULL
both	NULL
factors	NULL
are	NULL
abundantly	NULL
and	NULL
predominantly	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Thus	NULL
,	NULL
gene	NULL
activation	NULL
by	NULL
B-catenin	NULL
does	NULL
not	NULL
always	NULL
correlate	NULL
with	NULL
nuclear	NULL
localization	NULL
.	NULL

This	NULL
fact	NULL
,	NULL
coupled	NULL
with	NULL
our	NULL
observation	NULL
that	NULL
overexpression	NULL
of	NULL
B-catenin	NULL
can	NULL
squelch	NULL
activation	NULL
by	NULL
LEF-1-B-catenin	NULL
complexes	NULL
but	NULL
can	NULL
not	NULL
squelch	NULL
activation	NULL
by	NULL
the	NULL
herpesvirus	NULL
VP16	NULL
transcription	NULL
activator	NULL
,	NULL
leads	NULL
us	NULL
to	NULL
propose	NULL
that	NULL
an	NULL
additional	NULL
transcription	NULL
component	NULL
is	NULL
required	NULL
for	NULL
B-catenin	NULL
to	NULL
activate	NULL
gene	NULL
expression	NULL
.	NULL

Three	NULL
models	NULL
could	NULL
explain	NULL
how	NULL
a	NULL
small	NULL
deletion	NULL
of	NULL
19	NULL
aa	NULL
in	NULL
arm	NULL
repeat	NULL
6	NULL
of	NULL
B-catenin	NULL
causes	NULL
a	NULL
dramatic	NULL
change	NULL
in	NULL
sub	NULL
4512	NULL
PRIEVE	NULL
AND	NULL
WATERMAN	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

G4	NULL
UAS/Luc—	NULL
--	NULL
-|	NULL
:	NULL
Luciferase	NULL
A	NULL
o	NULL
50	NULL
100	NULL
150	NULL
4X	NULL
Cnt	NULL
20X	NULL
Cnt	NULL
V	NULL
4X	NULL
A19	NULL
G4LEF	NULL
+	NULL
B-cat	NULL
20X	NULL
A19	NULL
4X	NULL
ANA19	NULL
20X	NULL
ANA19	NULL
60X	NULL
ANLEF	NULL
4X	NULL
Cnt	NULL
G4VP16	NULL
20X	NULL
Cnt	NULL
4X	NULL
B-cat	NULL
20X	NULL
B-cat	NULL
Fold	NULL
Activation	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Excess	NULL
B-catenin	NULL
squelches	NULL
transactivation	NULL
of	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
but	NULL
not	NULL
transactivation	NULL
by	NULL
VP16	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Wild-type	NULL
B-catenin	NULL
expression	NULL
plasmid	NULL
(	NULL
750	NULL
ng	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
G4LEF	NULL
(	NULL
aa	NULL
1	NULL
to	NULL
256	NULL
)	NULL
,	NULL
1	NULL
g	NULL
of	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
the	NULL
following	NULL
plasmids	NULL
used	NULL
as	NULL
competitors	NULL
:	NULL
4-	NULL
and	NULL
20-fold	NULL
(	NULL
3	NULL
and	NULL
15	NULL
g	NULL
,	NULL
respectively	NULL
)	NULL
excess	NULL
amounts	NULL
of	NULL
A19	NULL
B-catenin	NULL
,	NULL
control	NULL
plasmid	NULL
(	NULL
empty	NULL
eukaryotic	NULL
expression	NULL
plasmid	NULL
)	NULL
,	NULL
and	NULL
ANA19	NULL
B-catenin	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
a	NULL
60-fold	NULL
(	NULL
3	NULL
pg	NULL
)	NULL
excess	NULL
amount	NULL
of	NULL
ANLEF	NULL
(	NULL
hLEF-1	NULL
aa	NULL
67	NULL
to	NULL
399	NULL
)	NULL
.	NULL

Excess	NULL
amounts	NULL
of	NULL
A19	NULL
and	NULL
ANA19	NULL
B-catenin	NULL
,	NULL
but	NULL
not	NULL
control	NULL
plasmid	NULL
or	NULL
ANLEF	NULL
,	NULL
were	NULL
able	NULL
to	NULL
squelch	NULL
wild-type	NULL
B-catenin-LEF-1	NULL
reporter	NULL
gene	NULL
activation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
G4VP16	NULL
(	NULL
750	NULL
ng	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
plasmid	NULL
and	NULL
the	NULL
following	NULL
plasmids	NULL
used	NULL
as	NULL
competitors	NULL
:	NULL
4-	NULL
and	NULL
20-fold	NULL
(	NULL
3	NULL
and	NULL
15	NULL
pg	NULL
,	NULL
respectively	NULL
)	NULL
excess	NULL
amounts	NULL
of	NULL
control	NULL
plasmid	NULL
or	NULL
a	NULL
wild-type	NULL
B-catenin	NULL
construct	NULL
.	NULL

Wild-type	NULL
B-catenin	NULL
does	NULL
not	NULL
squelch	NULL
G4VP16	NULL
transactivation	NULL
.	NULL

A	NULL
plasmid	NULL
(	NULL
0.5	NULL
pg	NULL
)	NULL
containing	NULL
the	NULL
lacZ	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CMV	NULL
promoter	NULL
was	NULL
cotransfected	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
transfection	NULL
efficiency	NULL
.	NULL

Error	NULL
bars	NULL
were	NULL
calculated	NULL
by	NULL
using	NULL
the	NULL
average	NULL
of	NULL
duplicate	NULL
points	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
replicate	NULL
experiments	NULL
.	NULL

Fold	NULL
activation	NULL
was	NULL
calculated	NULL
by	NULL
comparing	NULL
levels	NULL
of	NULL
luciferase	NULL
activity	NULL
to	NULL
the	NULL
G4	NULL
UAS/Luc	NULL
reporter	NULL
alone	NULL
.	NULL

cellular	NULL
localization	NULL
.	NULL

First	NULL
,	NULL
the	NULL
19-aa	NULL
deletion	NULL
could	NULL
have	NULL
unmasked	NULL
or	NULL
generated	NULL
a	NULL
strong	NULL
,	NULL
cryptic	NULL
NLS	NULL
.	NULL

Second	NULL
,	NULL
if	NULL
B-catenin	NULL
is	NULL
a	NULL
cytoplasmic-nuclear	NULL
shuttling	NULL
protein	NULL
with	NULL
export	NULL
capabilities	NULL
,	NULL
the	NULL
19-aa	NULL
deletion	NULL
might	NULL
prevent	NULL
export	NULL
such	NULL
that	NULL
newly	NULL
imported	NULL
A19	NULL
B-catenin	NULL
protein	NULL
remains	NULL
trapped	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
.	NULL

Third	NULL
,	NULL
B-catenin	NULL
might	NULL
be	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
plasma	NULL
membrane	NULL
,	NULL
and	NULL
the	NULL
19-aa	NULL
deletion	NULL
could	NULL
disrupt	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
interactions	NULL
.	NULL

The	NULL
first	NULL
model	NULL
is	NULL
unlikely	NULL
because	NULL
no	NULL
obvious	NULL
clustered	NULL
or	NULL
bipartite	NULL
NLS	NULL
sequence	NULL
is	NULL
evident	NULL
around	NULL
the	NULL
deleted	NULL
region	NULL
.	NULL

Furthermore	NULL
,	NULL
larger	NULL
deletions	NULL
that	NULL
remove	NULL
other	NULL
portions	NULL
of	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
also	NULL
create	NULL
nucleus-localized	NULL
protein	NULL
(	NULL
48	NULL
)	NULL
.	NULL

While	NULL
the	NULL
exact	NULL
region	NULL
specifying	NULL
nuclear	NULL
transport	NULL
has	NULL
not	NULL
been	NULL
defined	NULL
,	NULL
we	NULL
show	NULL
that	NULL
nuclear	NULL
import	NULL
can	NULL
be	NULL
carried	NULL
out	NULL
by	NULL
arm	NULL
repeats	NULL
1	NULL
through	NULL
9	NULL
(	NULL
MT10	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Others	NULL
have	NULL
also	NULL
observed	NULL
MT10	NULL
to	NULL
be	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
this	NULL
region	NULL
to	NULL
direct	NULL
nuclear	NULL
transport	NULL
is	NULL
remarkably	NULL
resilient	NULL
,	NULL
even	NULL
when	NULL
subjected	NULL
to	NULL
large	NULL
deletions	NULL
.	NULL

The	NULL
subcellular	NULL
localization	NULL
of	NULL
a	NULL
series	NULL
of	NULL
armadillo	NULL
deletion	NULL
mutants	NULL
was	NULL
determined	NULL
in	NULL
Drosophila	NULL
embryos	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Deletion	NULL
of	NULL
arm	NULL
re	NULL
peat	NULL
5	NULL
,	NULL
8	NULL
,	NULL
or	NULL
3	NULL
through	NULL
6	NULL
did	NULL
not	NULL
destroy	NULL
nuclear	NULL
localization	NULL
;	NULL
indeed	NULL
,	NULL
no	NULL
deletion	NULL
mutation	NULL
has	NULL
yet	NULL
been	NULL
reported	NULL
to	NULL
impair	NULL
nuclear	NULL
localization	NULL
.	NULL

Instead	NULL
,	NULL
deletion	NULL
of	NULL
repeats	NULL
3	NULL
through	NULL
6	NULL
created	NULL
a	NULL
constitutively	NULL
nucleus-localized	NULL
armadillo	NULL
protein	NULL
,	NULL
much	NULL
like	NULL
the	NULL
constitutively	NULL
localized	NULL
A19	NULL
mutant	NULL
described	NULL
here	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Either	NULL
nuclear	NULL
import	NULL
is	NULL
directed	NULL
by	NULL
a	NULL
discrete	NULL
signal	NULL
motif	NULL
that	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
specifically	NULL
deleted	NULL
or	NULL
it	NULL
is	NULL
specified	NULL
by	NULL
any	NULL
one	NULL
of	NULL
a	NULL
number	NULL
of	NULL
redundant	NULL
determinants	NULL
present	NULL
in	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
.	NULL

We	NULL
have	NULL
presented	NULL
data	NULL
to	NULL
suggest	NULL
that	NULL
wild-type	NULL
B-catenin	NULL
is	NULL
capable	NULL
of	NULL
nuclear	NULL
export	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

While	NULL
this	NULL
lends	NULL
support	NULL
to	NULL
the	NULL
second	NULL
model	NULL
,	NULL
in	NULL
which	NULL
A19	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
nucleus	NULL
because	NULL
it	NULL
has	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
be	NULL
exported	NULL
,	NULL
we	NULL
show	NULL
that	NULL
there	NULL
is	NULL
no	NULL
difference	NULL
between	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
A19	NULL
localization	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
second	NULL
model	NULL
is	NULL
insufficient	NULL
to	NULL
explain	NULL
the	NULL
contrasting	NULL
patterns	NULL
of	NULL
localization	NULL
.	NULL

Even	NULL
so	NULL
,	NULL
regulated	NULL
shifts	NULL
in	NULL
subcellular	NULL
localization	NULL
of	NULL
B-catenin	NULL
could	NULL
involve	NULL
a	NULL
modulation	NULL
of	NULL
the	NULL
relative	NULL
rates	NULL
of	NULL
import	NULL
and	NULL
export	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
observe	NULL
that	NULL
localization	NULL
of	NULL
B-catenin	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
can	NULL
be	NULL
shifted	NULL
from	NULL
cytoplasm	NULL
to	NULL
nu	NULL
Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
cleus	NULL
with	NULL
PMA-ionomycin	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Either	NULL
this	NULL
T-cell-activating	NULL
signal	NULL
modulates	NULL
relative	NULL
rates	NULL
of	NULL
import	NULL
and	NULL
export	NULL
,	NULL
as	NULL
it	NULL
does	NULL
for	NULL
NF-AT	NULL
,	NULL
or	NULL
it	NULL
somehow	NULL
causes	NULL
release	NULL
of	NULL
B-catenin	NULL
from	NULL
anchoring	NULL
sites	NULL
in	NULL
the	NULL
cytoplasm	NULL
or	NULL
plasma	NULL
membrane	NULL
.	NULL

Future	NULL
studies	NULL
of	NULL
B-catenin	NULL
localization	NULL
should	NULL
include	NULL
a	NULL
consideration	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
protein	NULL
to	NULL
shuttle	NULL
in	NULL
and	NULL
out	NULL
of	NULL
the	NULL
nucleus	NULL
.	NULL

Our	NULL
data	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
the	NULL
third	NULL
model	NULL
,	NULL
in	NULL
which	NULL
A19	NULL
localizes	NULL
to	NULL
the	NULL
nucleus	NULL
because	NULL
it	NULL
can	NULL
not	NULL
be	NULL
efficiently	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
and	NULL
plasma	NULL
membrane	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
A19	NULL
is	NULL
completely	NULL
defective	NULL
for	NULL
LEF/TCF	NULL
binding	NULL
,	NULL
but	NULL
we	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
it	NULL
no	NULL
longer	NULL
interacts	NULL
with	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
E-cadherin	NULL
or	NULL
the	NULL
cytoplasmic	NULL
tumor	NULL
suppressor	NULL
protein	NULL
APC	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
A19	NULL
may	NULL
not	NULL
be	NULL
easily	NULL
anchored	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
and	NULL
this	NULL
might	NULL
be	NULL
at	NULL
least	NULL
part	NULL
of	NULL
the	NULL
reason	NULL
for	NULL
the	NULL
predominant	NULL
nuclear	NULL
localization	NULL
of	NULL
this	NULL
mutant	NULL
.	NULL

In	NULL
light	NULL
of	NULL
the	NULL
dramatic	NULL
localization	NULL
of	NULL
A19	NULL
protein	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
it	NULL
is	NULL
surprising	NULL
that	NULL
it	NULL
binds	NULL
well	NULL
to	NULL
axin	NULL
.	NULL

Obviously	NULL
,	NULL
this	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
axin	NULL
does	NULL
not	NULL
prevent	NULL
nuclear	NULL
localization	NULL
,	NULL
but	NULL
more	NULL
work	NULL
is	NULL
necessary	NULL
to	NULL
determine	NULL
why	NULL
this	NULL
is	NULL
the	NULL
case	NULL
.	NULL

In	NULL
their	NULL
study	NULL
of	NULL
armadillo	NULL
deletion	NULL
mutants	NULL
in	NULL
Drosophila	NULL
embryos	NULL
,	NULL
Orsulic	NULL
and	NULL
Peifer	NULL
found	NULL
that	NULL
the	NULL
strongest	NULL
correlation	NULL
for	NULL
nuclear	NULL
accumulation	NULL
of	NULL
armadillo	NULL
mutants	NULL
was	NULL
a	NULL
loss	NULL
of	NULL
E-cadherin	NULL
binding	NULL
;	NULL
loss	NULL
of	NULL
interactions	NULL
with	NULL
other	NULL
cytoplasmic	NULL
proteins	NULL
discovered	NULL
more	NULL
recently	NULL
might	NULL
produce	NULL
the	NULL
same	NULL
effect	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Overexpressed	NULL
E-cadherin	NULL
protein	NULL
can	NULL
prevent	NULL
nuclear	NULL
localization	NULL
of	NULL
B-catenin	NULL
,	NULL
and	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
cadherins	NULL
act	NULL
as	NULL
regulators	NULL
of	NULL
B-catenin	NULL
signaling	NULL
by	NULL
depleting	NULL
the	NULL
soluble	NULL
cytoplasmic	NULL
pool	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
cytoplasmic	NULL
extracts	NULL
inhibit	NULL
nuclear	NULL
accumulation	NULL
of	NULL
B-catenin	NULL
in	NULL
digitonin-permeabilized	NULL
cells	NULL
,	NULL
again	NULL
suggesting	NULL
that	NULL
an	NULL
anchoring	NULL
activity	NULL
in	NULL
the	NULL
cytoplasmic	NULL
extract	NULL
prevents	NULL
B-catenin	NULL
from	NULL
transporting	NULL
through	NULL
nuclear	NULL
pores	NULL
.	NULL

Another	NULL
explanation	NULL
for	NULL
the	NULL
localization	NULL
pattern	NULL
of	NULL
A19	NULL
would	NULL
be	NULL
that	NULL
this	NULL
protein	NULL
is	NULL
much	NULL
more	NULL
stable	NULL
because	NULL
it	NULL
has	NULL
lost	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
conductin/axin/axil	NULL
and	NULL
APC	NULL
.	NULL

Indeed	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
stability	NULL
of	NULL
B-catenin	NULL
is	NULL
one	NULL
of	NULL
the	NULL
major	NULL
effects	NULL
of	NULL
the	NULL
Wat	NULL
signaling	NULL
cascade	NULL
,	NULL
and	NULL
this	NULL
increase	NULL
correlates	NULL
with	NULL
an	NULL
appearance	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
no	NULL
apparent	NULL
differences	NULL
between	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
wild-type	NULL
B-catenin	NULL
and	NULL
A19	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
is	NULL
surprising	NULL
given	NULL
that	NULL
A19	NULL
no	NULL
longer	NULL
binds	NULL
to	NULL
APC	NULL
.	NULL

A19	NULL
B-catenin	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
axin	NULL
as	NULL
well	NULL
as	NULL
,	NULL
if	NULL
not	NULL
better	NULL
than	NULL
,	NULL
wild-type	NULL
B-catenin	NULL
.	NULL

Perhaps	NULL
axin	NULL
is	NULL
still	NULL
capable	NULL
of	NULL
mediating	NULL
some	NULL
form	NULL
of	NULL
degradation	NULL
.	NULL

It	NULL
is	NULL
curious	NULL
that	NULL
A19	NULL
can	NULL
localize	NULL
to	NULL
nuclei	NULL
even	NULL
though	NULL
it	NULL
can	NULL
bind	NULL
to	NULL
axin	NULL
;	NULL
this	NULL
would	NULL
appear	NULL
to	NULL
be	NULL
inconsistent	NULL
with	NULL
a	NULL
cytoplasmic	NULL
anchoring	NULL
model	NULL
.	NULL

Perhaps	NULL
axin/conductin/axil	NULL
does	NULL
not	NULL
play	NULL
a	NULL
strong	NULL
role	NULL
in	NULL
sequestration	NULL
compared	NULL
to	NULL
E-cadherin	NULL
.	NULL

Immunolocalization	NULL
studies	NULL
of	NULL
exogenously	NULL
expressed	NULL
conduc-tin	NULL
show	NULL
that	NULL
the	NULL
protein	NULL
localizes	NULL
throughout	NULL
the	NULL
cell	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Another	NULL
possibility	NULL
is	NULL
that	NULL
axin	NULL
relocalizes	NULL
with	NULL
A19	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
our	NULL
data	NULL
support	NULL
a	NULL
model	NULL
in	NULL
which	NULL
varying	NULL
patterns	NULL
of	NULL
subcellular	NULL
localization	NULL
are	NULL
due	NULL
in	NULL
part	NULL
to	NULL
sequestration	NULL
by	NULL
B-catenin	NULL
binding	NULL
proteins	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
point	NULL
out	NULL
that	NULL
since	NULL
B-catenin	NULL
may	NULL
be	NULL
exported	NULL
,	NULL
subcellular	NULL
localization	NULL
might	NULL
also	NULL
be	NULL
influenced	NULL
by	NULL
sequestration	NULL
of	NULL
B-catenin	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
competing	NULL
rates	NULL
of	NULL
import	NULL
and	NULL
export	NULL
.	NULL

Early	NULL
reports	NULL
of	NULL
an	NULL
interaction	NULL
between	NULL
B-catenin	NULL
and	NULL
LEF/TCF	NULL
factors	NULL
showed	NULL
that	NULL
transiently	NULL
expressed	NULL
B-catenin	NULL
was	NULL
cytoplasmic	NULL
unless	NULL
coexpressed	NULL
with	NULL
a	NULL
LEF/TCF	NULL
protein	NULL
(	NULL
7	NULL
,	NULL
29	NULL
,	NULL
44	NULL
)	NULL
.	NULL

In	NULL
those	NULL
situations	NULL
,	NULL
coexpressed	NULL
LEF/TCF	NULL
proteins	NULL
may	NULL
have	NULL
been	NULL
preventing	NULL
cytoplasmic	NULL
anchoring	NULL
by	NULL
competing	NULL
with	NULL
cytoplasmic	NULL
or	NULL
plasma	NULL
membrane	NULL
proteins	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
same	NULL
or	NULL
overlapping	NULL
portion	NULL
of	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
.	NULL

But	NULL
it	NULL
is	NULL
also	NULL
plausible	NULL
that	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
transiently	NULL
expressed	NULL
LEF/TCF	NULL
protein	NULL
may	NULL
have	NULL
trapped	NULL
NUCLEAR	NULL
LOCALIZATION	NULL
AND	NULL
GENE	NULL
ACTIVATION	NULL
BY	NULL
B-CATENIN	NULL
_	NULL
4513	NULL
B-catenin	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
prevented	NULL
export	NULL
.	NULL

A	NULL
nuclear	NULL
entrapment	NULL
or	NULL
sequestering	NULL
of	NULL
B-catenin	NULL
by	NULL
LEF/TCF	NULL
proteins	NULL
may	NULL
explain	NULL
why	NULL
we	NULL
observe	NULL
that	NULL
transiently	NULL
expressed	NULL
B-catenin	NULL
is	NULL
predominantly	NULL
nuclear	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
endogenous	NULL
LEF-1	NULL
and	NULL
TCF-1	NULL
(	NULL
Jurkat	NULL
)	NULL
but	NULL
is	NULL
cytoplasm	NULL
or	NULL
membrane	NULL
bound	NULL
in	NULL
cells	NULL
that	NULL
express	NULL
little	NULL
or	NULL
no	NULL
LEF/TCF	NULL
protein	NULL
(	NULL
PBMCs	NULL
and	NULL
Cos-1	NULL
cells	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
idea	NULL
is	NULL
the	NULL
fact	NULL
that	NULL
wild-type	NULL
B-catenin	NULL
can	NULL
not	NULL
be	NULL
exported	NULL
from	NULL
Jurkat	NULL
nuclei	NULL
(	NULL
55a	NULL
)	NULL
.	NULL

In	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
NIH	NULL
3T3	NULL
and	NULL
Cos-1	NULL
cells	NULL
,	NULL
overexpression	NULL
of	NULL
LEF-1	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
direct	NULL
endogenous	NULL
B-catenin	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
27	NULL
,	NULL
53a	NULL
)	NULL
.	NULL

Interest-ingly	NULL
,	NULL
Wat-1	NULL
treatment	NULL
of	NULL
NIH	NULL
3T3	NULL
cells	NULL
is	NULL
also	NULL
insufficient	NULL
to	NULL
cause	NULL
nuclear	NULL
accumulation	NULL
,	NULL
even	NULL
though	NULL
it	NULL
stimulates	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
total	NULL
levels	NULL
of	NULL
B-catenin	NULL
protein	NULL
.	NULL

Instead	NULL
,	NULL
it	NULL
is	NULL
necessary	NULL
to	NULL
coexpress	NULL
LEF-1	NULL
and	NULL
Wat-1	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
to	NULL
drive	NULL
endogenous	NULL
B-catenin	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
keep	NULL
it	NULL
there	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Once	NULL
B-catenin	NULL
accumulates	NULL
in	NULL
nuclei	NULL
,	NULL
it	NULL
complexes	NULL
with	NULL
LEF/TCF	NULL
proteins	NULL
to	NULL
regulate	NULL
gene	NULL
expression	NULL
.	NULL

B-Catenin	NULL
and	NULL
LEF/TCF	NULL
proteins	NULL
have	NULL
been	NULL
able	NULL
to	NULL
elicit	NULL
increases	NULL
in	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
including	NULL
Neuro	NULL
2A	NULL
,	NULL
NIH	NULL
3T3	NULL
,	NULL
IIA1.6	NULL
lymphocytes	NULL
,	NULL
and	NULL
others	NULL
.	NULL

These	NULL
data	NULL
and	NULL
others	NULL
,	NULL
including	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
C-terminal	NULL
hydrophilic	NULL
region	NULL
of	NULL
armadillo	NULL
to	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
yeast	NULL
,	NULL
have	NULL
led	NULL
to	NULL
a	NULL
straightforward	NULL
model	NULL
in	NULL
which	NULL
recruitment	NULL
of	NULL
B-catenin	NULL
by	NULL
a	NULL
LEF/TCF	NULL
protein	NULL
to	NULL
the	NULL
promoter	NULL
template	NULL
may	NULL
be	NULL
all	NULL
that	NULL
is	NULL
required	NULL
to	NULL
activate	NULL
gene	NULL
transcription	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
Cos-1	NULL
cells	NULL
,	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
PBMCs	NULL
could	NULL
support	NULL
B-catenin-dependent	NULL
activation	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
and	NULL
whether	NULL
the	NULL
level	NULL
of	NULL
reporter	NULL
gene	NULL
activation	NULL
correlated	NULL
with	NULL
the	NULL
level	NULL
of	NULL
nuclear	NULL
localization	NULL
in	NULL
different	NULL
cells	NULL
,	NULL
and	NULL
it	NULL
did	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
activation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
this	NULL
complex	NULL
varied	NULL
greatly	NULL
between	NULL
cell	NULL
types	NULL
.	NULL

LEF-1	NULL
and	NULL
B-catenin	NULL
activated	NULL
reporter	NULL
gene	NULL
expression	NULL
poorly	NULL
in	NULL
Cos-1	NULL
cells	NULL
.	NULL

Wild-type	NULL
B-catenin	NULL
does	NULL
not	NULL
localize	NULL
efficiently	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
and	NULL
coexpression	NULL
of	NULL
LEF-1	NULL
does	NULL
not	NULL
force	NULL
a	NULL
shift	NULL
of	NULL
B-catenin	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
53a	NULL
)	NULL
.	NULL

Similar	NULL
observations	NULL
have	NULL
been	NULL
made	NULL
with	NULL
NIH	NULL
3T3	NULL
cells	NULL
;	NULL
LEF-1	NULL
overexpression	NULL
is	NULL
insufficient	NULL
to	NULL
relocalize	NULL
B-catenin	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
low	NULL
level	NULL
of	NULL
activation	NULL
in	NULL
Cos-1	NULL
cells	NULL
could	NULL
simply	NULL
correlate	NULL
with	NULL
the	NULL
poor	NULL
ability	NULL
of	NULL
B-catenin	NULL
to	NULL
transport	NULL
to	NULL
nuclei	NULL
.	NULL

This	NULL
is	NULL
clearly	NULL
not	NULL
the	NULL
case	NULL
for	NULL
normal	NULL
peripheral	NULL
lymphocytes	NULL
:	NULL
LEF-1	NULL
and	NULL
B-catenin	NULL
could	NULL
not	NULL
activate	NULL
transcription	NULL
in	NULL
PBMCs	NULL
even	NULL
when	NULL
PMA	NULL
and	NULL
ionomycin	NULL
were	NULL
added	NULL
to	NULL
direct	NULL
B-catenin	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
are	NULL
certainly	NULL
capable	NULL
of	NULL
supporting	NULL
reporter	NULL
gene	NULL
activation	NULL
,	NULL
as	NULL
they	NULL
have	NULL
been	NULL
used	NULL
extensively	NULL
to	NULL
study	NULL
regulation	NULL
of	NULL
interleukin	NULL
2	NULL
promoter	NULL
activity	NULL
(	NULL
30	NULL
)	NULL
,	NULL
and	NULL
we	NULL
observe	NULL
a	NULL
115-fold	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
by	NULL
G4VP16	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Perhaps	NULL
an	NULL
inhibitory	NULL
factor	NULL
is	NULL
abundant	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
,	NULL
or	NULL
a	NULL
third	NULL
required	NULL
component	NULL
or	NULL
modification	NULL
of	NULL
B-catenin	NULL
or	NULL
LEF-1	NULL
protein	NULL
is	NULL
limiting	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

We	NULL
tested	NULL
these	NULL
notions	NULL
by	NULL
overexpressing	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
mutants	NULL
that	NULL
could	NULL
not	NULL
engage	NULL
in	NULL
complex	NULL
formation	NULL
to	NULL
see	NULL
whether	NULL
these	NULL
mutants	NULL
could	NULL
act	NULL
negatively	NULL
by	NULL
squelching	NULL
a	NULL
required	NULL
cofactor	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

The	NULL
A19	NULL
mutant	NULL
was	NULL
able	NULL
to	NULL
effectively	NULL
squelch	NULL
reporter	NULL
gene	NULL
activation	NULL
when	NULL
provided	NULL
at	NULL
20-fold	NULL
excess	NULL
over	NULL
wild-type	NULL
B-catenin	NULL
,	NULL
as	NULL
was	NULL
a	NULL
related	NULL
mutant	NULL
missing	NULL
the	NULL
N-terminal	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

A	NULL
60-fold	NULL
excess	NULL
of	NULL
LEF-1	NULL
missing	NULL
the	NULL
B-catenin	NULL
binding	NULL
domain	NULL
did	NULL
not	NULL
squelch	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
a	NULL
region	NULL
in	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
or	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
the	NULL
protein	NULL
is	NULL
able	NULL
to	NULL
specifically	NULL
sequester	NULL
a	NULL
required	NULL
positive	NULL
cofactor	NULL
for	NULL
activation	NULL
,	NULL
although	NULL
they	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
an	NULL
additional	NULL
inhibitory	NULL
factor	NULL
is	NULL
present	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
.	NULL

The	NULL
sequestered	NULL
factor	NULL
is	NULL
not	NULL
likely	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
general	NULL
steps	NULL
of	NULL
transcription	NULL
downstream	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
initiation	NULL
,	NULL
because	NULL
B-catenin	NULL
does	NULL
not	NULL
squelch	NULL
G4VP16	NULL
activation	NULL
.	NULL

The	NULL
transcrip-	NULL
4514	NULL
PRIEVE	NULL
AND	NULL
WATERMAN	NULL
tion	NULL
activation	NULL
domain	NULL
of	NULL
VP16	NULL
is	NULL
highly	NULL
acidic	NULL
and	NULL
known	NULL
to	NULL
affect	NULL
both	NULL
initiation	NULL
and	NULL
processivity	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
through	NULL
multiple	NULL
contacts	NULL
with	NULL
basal	NULL
factors	NULL
and	NULL
TATA	NULL
binding	NULL
protein-associated	NULL
factors	NULL
(	NULL
8	NULL
,	NULL
24	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
A19	NULL
squelching	NULL
activity	NULL
must	NULL
not	NULL
be	NULL
interfering	NULL
with	NULL
these	NULL
contacts	NULL
or	NULL
downstream	NULL
events	NULL
.	NULL

The	NULL
C-terminal	NULL
domain	NULL
of	NULL
B-catenin	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
a	NULL
transcription	NULL
activation	NULL
domain	NULL
(	NULL
48	NULL
,	NULL
63	NULL
)	NULL
.	NULL

However	NULL
,	NULL
most	NULL
of	NULL
the	NULL
C-terminal	NULL
region	NULL
is	NULL
not	NULL
nearly	NULL
as	NULL
well	NULL
conserved	NULL
between	NULL
catenin	NULL
orthologs	NULL
and	NULL
plakoglobin	NULL
(	NULL
which	NULL
can	NULL
also	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
)	NULL
as	NULL
the	NULL
arm	NULL
repeats	NULL
,	NULL
making	NULL
it	NULL
difficult	NULL
to	NULL
identify	NULL
a	NULL
specific	NULL
conserved	NULL
region	NULL
as	NULL
a	NULL
candidate	NULL
transcription	NULL
activation	NULL
domain	NULL
.	NULL

Perhaps	NULL
the	NULL
C-terminal	NULL
domains	NULL
adopt	NULL
similar	NULL
functional	NULL
structures	NULL
despite	NULL
their	NULL
modest	NULL
level	NULL
of	NULL
sequence	NULL
similarity	NULL
,	NULL
or	NULL
they	NULL
each	NULL
activate	NULL
transcription	NULL
through	NULL
different	NULL
sequences	NULL
.	NULL

For	NULL
the	NULL
squelching	NULL
results	NULL
presented	NULL
here	NULL
,	NULL
it	NULL
is	NULL
equally	NULL
likely	NULL
that	NULL
a	NULL
region	NULL
other	NULL
than	NULL
the	NULL
divergent	NULL
C	NULL
terminus	NULL
is	NULL
responsible	NULL
and	NULL
that	NULL
a	NULL
region	NULL
of	NULL
the	NULL
arm	NULL
repeat	NULL
array	NULL
,	NULL
not	NULL
perturbed	NULL
by	NULL
the	NULL
A19	NULL
mutation	NULL
,	NULL
is	NULL
competing	NULL
for	NULL
a	NULL
required	NULL
transcription	NULL
component	NULL
.	NULL

Pontin52	NULL
,	NULL
a	NULL
nuclear	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
Tata	NULL
binding	NULL
protein	NULL
,	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
arm	NULL
repeats	NULL
2	NULL
through	NULL
5	NULL
of	NULL
B-catenin	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Pontin52	NULL
can	NULL
be	NULL
coimmunoprecipitated	NULL
within	NULL
a	NULL
larger	NULL
complex	NULL
containing	NULL
B-catenin	NULL
and	NULL
LEF-1	NULL
and	NULL
is	NULL
proposed	NULL
to	NULL
provide	NULL
a	NULL
bridging	NULL
function	NULL
between	NULL
LEF-1-B-catenin	NULL
complexes	NULL
and	NULL
basal	NULL
transcription	NULL
machinery	NULL
.	NULL

If	NULL
this	NULL
is	NULL
true	NULL
,	NULL
Pontin52	NULL
could	NULL
presumably	NULL
be	NULL
a	NULL
component	NULL
that	NULL
is	NULL
squelched	NULL
by	NULL
excess	NULL
A19	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
we	NULL
show	NULL
that	NULL
MT10	NULL
,	NULL
a	NULL
B-catenin	NULL
deletion	NULL
mutant	NULL
containing	NULL
arm	NULL
repeats	NULL
1	NULL
through	NULL
9	NULL
,	NULL
does	NULL
not	NULL
activate	NULL
reporter	NULL
gene	NULL
expression	NULL
even	NULL
though	NULL
it	NULL
should	NULL
be	NULL
fully	NULL
capable	NULL
of	NULL
binding	NULL
Pontin52	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
an	NULL
additional	NULL
protein	NULL
or	NULL
complex	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
involved	NULL
.	NULL

Clearly	NULL
,	NULL
more	NULL
work	NULL
is	NULL
necessary	NULL
to	NULL
test	NULL
these	NULL
possibilities	NULL
.	NULL

Three	NULL
additional	NULL
nuclear	NULL
proteins	NULL
,	NULL
Groucho	NULL
,	NULL
CREB	NULL
binding	NULL
protein	NULL
(	NULL
CBP	NULL
)	NULL
,	NULL
and	NULL
Teashirt	NULL
,	NULL
have	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
either	NULL
LEF-1	NULL
(	NULL
Groucho	NULL
and	NULL
CBP	NULL
)	NULL
or	NULL
B-catenin/	NULL
armadillo	NULL
(	NULL
Teashirt	NULL
)	NULL
(	NULL
12	NULL
,	NULL
19	NULL
,	NULL
38	NULL
,	NULL
56	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Groucho	NULL
,	NULL
a	NULL
transcriptional	NULL
repressor	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
TCF-1	NULL
near	NULL
the	NULL
HMG	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
12	NULL
,	NULL
38	NULL
,	NULL
56	NULL
)	NULL
.	NULL

CBP	NULL
,	NULL
a	NULL
coactivator-acetyltransferase	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
HMG	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
LEF-1	NULL
and	NULL
is	NULL
proposed	NULL
to	NULL
antagonize	NULL
B-catenin	NULL
binding	NULL
(	NULL
65	NULL
)	NULL
.	NULL

For	NULL
our	NULL
experiments	NULL
,	NULL
we	NULL
have	NULL
used	NULL
a	NULL
G4LEF	NULL
(	NULL
aa	NULL
1	NULL
to	NULL
256	NULL
)	NULL
expression	NULL
plasmid	NULL
that	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
Groucho	NULL
and	NULL
CBP	NULL
binding	NULL
regions	NULL
.	NULL

Thus	NULL
the	NULL
lack	NULL
of	NULL
activation	NULL
obtained	NULL
in	NULL
normal	NULL
T	NULL
lymphocytes	NULL
is	NULL
not	NULL
a	NULL
result	NULL
of	NULL
Groucho	NULL
repression	NULL
or	NULL
antagonistic	NULL
actions	NULL
by	NULL
CBP	NULL
.	NULL

Teashirt	NULL
,	NULL
a	NULL
Zn-finger	NULL
Drosophila	NULL
protein	NULL
expressed	NULL
in	NULL
a	NULL
trunk-specific	NULL
pattern	NULL
,	NULL
requires	NULL
a	NULL
direct	NULL
interaction	NULL
with	NULL
armadillo/B-catenin	NULL
to	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
some	NULL
Wingless	NULL
gene	NULL
targets	NULL
but	NULL
not	NULL
others	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Teashirt	NULL
may	NULL
be	NULL
a	NULL
tissue-specifically	NULL
expressed	NULL
DNA	NULL
binding	NULL
protein	NULL
that	NULL
recruits	NULL
B-catenin	NULL
to	NULL
a	NULL
subset	NULL
of	NULL
gene	NULL
targets	NULL
independent	NULL
of	NULL
LEF-1	NULL
,	NULL
or	NULL
it	NULL
may	NULL
be	NULL
a	NULL
coactivating	NULL
component	NULL
of	NULL
a	NULL
larger	NULL
complex	NULL
involving	NULL
all	NULL
three	NULL
proteins	NULL
.	NULL

Whether	NULL
a	NULL
mammalian	NULL
ortholog	NULL
of	NULL
Teashirt	NULL
is	NULL
expressed	NULL
in	NULL
Jurkat	NULL
cells	NULL
or	NULL
normal	NULL
T	NULL
lymphocytes	NULL
is	NULL
not	NULL
known	NULL
,	NULL
but	NULL
it	NULL
is	NULL
unlikely	NULL
.	NULL

It	NULL
is	NULL
more	NULL
likely	NULL
that	NULL
there	NULL
are	NULL
other	NULL
B-catenin	NULL
binding	NULL
proteins	NULL
in	NULL
addition	NULL
to	NULL
LEF/TCFs	NULL
,	NULL
Pontin52	NULL
,	NULL
and	NULL
Teashirt	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
transcription	NULL
activation	NULL
.	NULL

Future	NULL
studies	NULL
should	NULL
be	NULL
focused	NULL
on	NULL
identifying	NULL
these	NULL
additional	NULL
factors	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Chris	NULL
Hughes	NULL
,	NULL
Javier	NULL
Mestas	NULL
,	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Hughes	NULL
laboratory	NULL
for	NULL
invaluable	NULL
help	NULL
with	NULL
transfection	NULL
of	NULL
PBMC	NULL
preparations	NULL
and	NULL
generous	NULL
sharing	NULL
of	NULL
time	NULL
and	NULL
reagents	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Barry	NULL
Gumbiner	NULL
for	NULL
sharing	NULL
full-length	NULL
and	NULL
MT1O0	NULL
B-catenin	NULL
constructs	NULL
and	NULL
to	NULL
Steve	NULL
Adam	NULL
for	NULL
the	NULL
GST-importin	NULL
B	NULL
plasmid	NULL
.	NULL

Many	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

thanks	NULL
go	NULL
to	NULL
Harry	NULL
Mangalam	NULL
,	NULL
Karine	NULL
Hovanes	NULL
,	NULL
Chris	NULL
Hughes	NULL
,	NULL
Bert	NULL
Semler	NULL
,	NULL
Larry	NULL
Marsh	NULL
,	NULL
and	NULL
Adeela	NULL
Syed	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grant	NULL
CA	NULL
62069	NULL
from	NULL
NIH	NULL
and	NULL
in	NULL
part	NULL
by	NULL
grant	NULL
RPG-97-156-CSM	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
and	NULL
by	NULL
the	NULL
Chao	NULL
Cancer	NULL
Center	NULL
at	NULL
UCI	NULL
.	NULL

M.L.W	NULL
.	NULL

is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Developmental	NULL
Biology	NULL
Center	NULL
and	NULL
the	NULL
Cancer	NULL
Research	NULL
Institute	NULL
at	NULL
UCL	NULL
REFERENCES	NULL
1	NULL
.	NULL

Aberle	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Bauer	NULL
,	NULL
J.	NULL
Stappert	NULL
,	NULL
A.	NULL
Kispert	NULL
,	NULL
and	NULL
R.	NULL
Kemler	NULL
.	NULL

1997	NULL
.	NULL

Beta-catenin	NULL
is	NULL
a	NULL
target	NULL
for	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3797-3804	NULL
.	NULL

2	NULL
.	NULL

Adam	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
R.	NULL
E.	NULL
Sterne-Marr	NULL
,	NULL
and	NULL
L.	NULL
Gerace	NULL
.	NULL

1990	NULL
.	NULL

Nuclear	NULL
protein	NULL
import	NULL
in	NULL
permeabilized	NULL
mammalian	NULL
cells	NULL
requires	NULL
soluble	NULL
cytoplasmic	NULL
factors	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

111:807-816	NULL
.	NULL

3	NULL
.	NULL

Bauer	NULL
,	NULL
A.	NULL
,	NULL
O.	NULL
Huber	NULL
,	NULL
and	NULL
R.	NULL
Kemler	NULL
.	NULL

1998	NULL
.	NULL

Pontin52	NULL
,	NULL
an	NULL
interaction	NULL
partner	NULL
of	NULL
beta-catenin	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
binding	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:14787-14792	NULL
.	NULL

4	NULL
.	NULL

Beals	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
Clipstone	NULL
,	NULL
S.	NULL
Ho	NULL
,	NULL
and	NULL
G.	NULL
Crabtree	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
NF-ATe	NULL
by	NULL
a	NULL
calcineurin-dependent	NULL
,	NULL
cyclosporin-sensitive	NULL
intramolecular	NULL
interaction	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:824-834	NULL
.	NULL

5	NULL
.	NULL

Beals	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Sheridan	NULL
,	NULL
C.	NULL
Turck	NULL
,	NULL
P.	NULL
Gardner	NULL
,	NULL
and	NULL
G.	NULL
Crabtree	NULL
.	NULL

1997	NULL
.	NULL

Nuclear	NULL
export	NULL
of	NULL
NF-ATe	NULL
enhanced	NULL
by	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
.	NULL

Science	NULL
275	NULL
:	NULL
1930-1934	NULL
.	NULL

6	NULL
.	NULL

Behrens	NULL
,	NULL
J.	NULL
,	NULL
B.-A	NULL
.	NULL

Jerchow	NULL
,	NULL
M.	NULL
Wurtele	NULL
,	NULL
J.	NULL
Grimm	NULL
,	NULL
C.	NULL
Asbrand	NULL
,	NULL
R.	NULL
Wirtz	NULL
,	NULL
M.	NULL
Kuhn	NULL
,	NULL
D.	NULL
Wedlich	NULL
,	NULL
and	NULL
W.	NULL
Birchmeier	NULL
.	NULL

1998	NULL
.	NULL

Functional	NULL
interaction	NULL
of	NULL
an	NULL
axin	NULL
homolog	NULL
,	NULL
conductin	NULL
,	NULL
with	NULL
B-catenin	NULL
,	NULL
APC	NULL
and	NULL
GSK3B	NULL
.	NULL

Science	NULL
280:596-599	NULL
.	NULL

7	NULL
.	NULL

Behrens	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
P.	NULL
von	NULL
Kries	NULL
,	NULL
M.	NULL
Kuh	NULL
,	NULL
L.	NULL
Bruhn	NULL
,	NULL
D.	NULL
Wedlich	NULL
,	NULL
R.	NULL
and	NULL
W.	NULL
Birchmeier	NULL
.	NULL

1996	NULL
.	NULL

Functional	NULL
interaction	NULL
of	NULL
B-catenin	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
LEF-1	NULL
.	NULL

Nature	NULL
382:638-642	NULL
.	NULL

8	NULL
.	NULL

Blau	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Xiao	NULL
,	NULL
S.	NULL
McCracken	NULL
,	NULL
P.	NULL
O'Hare	NULL
,	NULL
J.	NULL
Greenblatt	NULL
,	NULL
and	NULL
D.	NULL
Bentley	NULL
.	NULL

1996	NULL
.	NULL

Three	NULL
functional	NULL
classes	NULL
of	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2044-2055	NULL
.	NULL

9	NULL
.	NULL

Brown	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Moon	NULL
.	NULL

1998	NULL
.	NULL

Wat	NULL
signaling	NULL
:	NULL
why	NULL
is	NULL
everything	NULL
so	NULL
negative	NULL
?	NULL

Curr	NULL
.	NULL

Opinion	NULL
Cell	NULL
Biol	NULL
.	NULL

10:182-187	NULL
.	NULL

10	NULL
.	NULL

Cadigan	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
Nusse	NULL
.	NULL

1998	NULL
.	NULL

Wnt	NULL
signaling	NULL
:	NULL
a	NULL
common	NULL
theme	NULL
in	NULL
animal	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11:3286-3305	NULL
.	NULL

11	NULL
.	NULL

Carlsson	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Waterman	NULL
,	NULL
and	NULL
K.	NULL
Jones	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
hLEF/TCF-l	NULL
«	NULL
HMG	NULL
protein	NULL
contains	NULL
a	NULL
context-dependent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
that	NULL
induces	NULL
the	NULL
TCRa	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2418-2430	NULL
.	NULL

12	NULL
.	NULL

Cavallo	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
R.	NULL
T.	NULL
Cox	NULL
,	NULL
M.	NULL
M.	NULL
Moline	NULL
,	NULL
J.	NULL
Roose	NULL
,	NULL
G.	NULL
A.	NULL
Polevoy	NULL
,	NULL
H.	NULL
Clevers	NULL
,	NULL
M.	NULL
Peifer	NULL
,	NULL
and	NULL
A.	NULL
Bejsovec	NULL
.	NULL

1998	NULL
.	NULL

Drosophila	NULL
Tef	NULL
and	NULL
Groucho	NULL
interact	NULL
to	NULL
repress	NULL
Wingless	NULL
signalling	NULL
activity	NULL
.	NULL

Nature	NULL
395:604-608	NULL
.	NULL

13	NULL
.	NULL

Conti	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Uy	NULL
,	NULL
L.	NULL
Leighton	NULL
,	NULL
G.	NULL
Blobel	NULL
,	NULL
and	NULL
J.	NULL
Kuriyan	NULL
.	NULL

1998	NULL
.	NULL

Crystallographic	NULL
analysis	NULL
of	NULL
the	NULL
recognition	NULL
of	NULL
a	NULL
nuclear	NULL
localization	NULL
signal	NULL
by	NULL
the	NULL
nuclear	NULL
import	NULL
factor	NULL
karyopherin	NULL
«	NULL
.	NULL

Cell	NULL
94:193-204	NULL
.	NULL

14	NULL
.	NULL

Cook	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Fry	NULL
,	NULL
K.	NULL
Hughes	NULL
,	NULL
R.	NULL
Sumathipala	NULL
,	NULL
J.	NULL
Woodgett	NULL
,	NULL
and	NULL
T.	NULL
Dale	NULL
.	NULL

1996	NULL
.	NULL

Wingless	NULL
inactivates	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
via	NULL
an	NULL
intracellular	NULL
signalling	NULL
pathway	NULL
which	NULL
involves	NULL
a	NULL
protein	NULL
kinase	NULL
C.	NULL
EMBO	NULL
J	NULL
.	NULL

15:4526-4536	NULL
.	NULL

15	NULL
.	NULL

Dale	NULL
,	NULL
T.	NULL
C.	NULL
1998	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
the	NULL
Wnt	NULL
family	NULL
of	NULL
ligands	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

329:209-223	NULL
.	NULL

16	NULL
.	NULL

Fagotto	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Funayama	NULL
,	NULL
U.	NULL
Gluck	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Gumbiner	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
to	NULL
cadherins	NULL
antagonizes	NULL
the	NULL
signaling	NULL
activity	NULL
of	NULL
B-catenin	NULL
during	NULL
axis	NULL
formation	NULL
in	NULL
Xenopus	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

132:1105-1114	NULL
.	NULL

17	NULL
.	NULL

Fagotto	NULL
,	NULL
F.	NULL
,	NULL
U.	NULL
Gluck	NULL
,	NULL
and	NULL
B.	NULL
Gumbiner	NULL
.	NULL

1998	NULL
.	NULL

Nuclear	NULL
localization	NULL
signal-independent	NULL
and	NULL
importin/karyopherin-independent	NULL
nuclear	NULL
import	NULL
of	NULL
beta-catenin	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

8:181-190	NULL
.	NULL

18	NULL
.	NULL

Funayama	NULL
,	NULL
N.	NULL
,	NULL
F.	NULL
Fagotto	NULL
,	NULL
P.	NULL
McCrea	NULL
,	NULL
and	NULL
B.	NULL
M.	NULL
Gumbiner	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
axis	NULL
induction	NULL
by	NULL
the	NULL
armadillo	NULL
repeat	NULL
domain	NULL
of	NULL
beta-catenin	NULL
:	NULL
evidence	NULL
for	NULL
intracellular	NULL
signaling	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

128:959-968	NULL
.	NULL

19	NULL
.	NULL

Gallet	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Erkner	NULL
,	NULL
B.	NULL
Charroux	NULL
,	NULL
L.	NULL
Fasano	NULL
,	NULL
and	NULL
S.	NULL
Kerridge	NULL
.	NULL

1998	NULL
.	NULL

Trunk-specific	NULL
modulation	NULL
of	NULL
wingless	NULL
signalling	NULL
in	NULL
Drosophila	NULL
by	NULL
teashirt	NULL
binding	NULL
to	NULL
armadillo	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

8:893-902	NULL
.	NULL

20	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Cox	NULL
,	NULL
and	NULL
R.	NULL
Grosscheldl	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HMG	NULL
domain	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
bends	NULL
DNA	NULL
and	NULL
facilitates	NULL
assembly	NULL
of	NULL
functional	NULL
nucleo-protein	NULL
structures	NULL
.	NULL

Cell	NULL
69:185-196	NULL
.	NULL

21	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1993	NULL
.	NULL

LEF-1	NULL
contains	NULL
an	NULL
activation	NULL
domain	NULL
that	NULL
stimulates	NULL
transcription	NULL
only	NULL
in	NULL
a	NULL
specific	NULL
context	NULL
of	NULL
factor-binding	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4667-4676	NULL
.	NULL

22	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Kingsley	NULL
,	NULL
J.	NULL
R.	NULL
Kirshner	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1995	NULL
.	NULL

Assembly	NULL
and	NULL
function	NULL
of	NULL
a	NULL
TCR	NULL
alpha	NULL
enhancer	NULL
complex	NULL
is	NULL
dependent	NULL
on	NULL
LEF-1-induced	NULL
DNA	NULL
bending	NULL
and	NULL
multiple	NULL
protein-protein	NULL
interactions	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9995-1008	NULL
.	NULL

23	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
J.	NULL
Pagel	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1997	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
DNA	NULL
bending	NULL
and	NULL
unwinding	NULL
by	NULL
the	NULL
high	NULL
mobility	NULL
group	NULL
domain	NULL
of	NULL
LEF-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:12845-12850	NULL
.	NULL

24	NULL
.	NULL

Goodrich	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
C.	NULL
J.	NULL
Thut	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1993	NULL
.	NULL

Drosophila	NULL
TAFII40	NULL
interacts	NULL
with	NULL
both	NULL
a	NULL
VP16	NULL
activation	NULL
domain	NULL
and	NULL
the	NULL
basal	NULL
transcription	NULL
factor	NULL
TFIIB	NULL
.	NULL

Cell	NULL
75:519-530	NULL
.	NULL

Vor	NULL
.	NULL

19	NULL
,	NULL
1999	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Gorlich	NULL
,	NULL
D.	NULL
,	NULL
S.	NULL
Kostak	NULL
,	NULL
R.	NULL
Kraft	NULL
,	NULL
C.	NULL
Dingwall	NULL
,	NULL
R.	NULL
A.	NULL
Laskey	NULL
,	NULL
E.	NULL
Hartmann	NULL
,	NULL
and	NULL
S.	NULL
Prehn	NULL
.	NULL

1995	NULL
.	NULL

Two	NULL
different	NULL
subunits	NULL
of	NULL
importin	NULL
cooperate	NULL
to	NULL
recognize	NULL
nuclear	NULL
localization	NULL
signals	NULL
and	NULL
bind	NULL
them	NULL
to	NULL
the	NULL
nuclear	NULL
envelope	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

5:383-392	NULL
.	NULL

Gorlich	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
I.	NULL
W.	NULL
Mattaj	NULL
.	NULL

1996	NULL
.	NULL

Nucleocytoplasmic	NULL
transport	NULL
.	NULL

Science	NULL
271:1513-1518	NULL
.	NULL

Hsu	NULL
,	NULL
S.-C.	NULL
,	NULL
J.	NULL
Galceran	NULL
,	NULL
and	NULL
R.	NULL
GrosschedI	NULL
.	NULL

1998	NULL
.	NULL

Modulation	NULL
of	NULL
transcriptional	NULL
regulation	NULL
by	NULL
LEF-1	NULL
in	NULL
response	NULL
to	NULL
Want-1	NULL
signaling	NULL
and	NULL
association	NULL
with	NULL
B-catenin	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:4807-4818	NULL
.	NULL

Huber	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
W.	NULL
J.	NULL
Nelson	NULL
,	NULL
and	NULL
W.	NULL
I.	NULL
Weis	NULL
.	NULL

1997	NULL
.	NULL

Three-dimensional	NULL
structure	NULL
of	NULL
the	NULL
armadillo	NULL
repeat	NULL
region	NULL
of	NULL
B-catenin	NULL
.	NULL

Cell	NULL
90:871-882	NULL
.	NULL

Huber	NULL
,	NULL
O.	NULL
,	NULL
R.	NULL
Korn	NULL
,	NULL
J.	NULL
McLaughlin	NULL
,	NULL
M.	NULL
Ohsugi	NULL
,	NULL
B.	NULL
Herrmann	NULL
,	NULL
and	NULL
R.	NULL
Kemler	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
localization	NULL
of	NULL
beta-catenin	NULL
by	NULL
interaction	NULL
with	NULL
transcription	NULL
factor	NULL
LEF-1	NULL
.	NULL

Mech	NULL
.	NULL

Dev	NULL
.	NULL

59:3-10	NULL
.	NULL

Hughes	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Pober	NULL
.	NULL

1996	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
interleukin-2	NULL
gene	NULL
in	NULL
normal	NULL
human	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
.	NULL

Convergence	NULL
of	NULL
costimulatory	NULL
signals	NULL
and	NULL
differences	NULL
from	NULL
transformed	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:5369-5377	NULL
.	NULL

Hulsken	NULL
,	NULL
J.	NULL
,	NULL
W.	NULL
Birchmeier	NULL
,	NULL
and	NULL
J.	NULL
Behrens	NULL
.	NULL

1994	NULL
.	NULL

E-cadherin	NULL
and	NULL
APC	NULL
compete	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
B-catenin	NULL
and	NULL
the	NULL
cytoskeleton	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

127:2061-2069	NULL
.	NULL

Ikeda	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Kishida	NULL
,	NULL
H.	NULL
Yamamoto	NULL
,	NULL
H.	NULL
Murai	NULL
,	NULL
S.	NULL
Koyama	NULL
,	NULL
and	NULL
A.	NULL
Kikuchi	NULL
.	NULL

1998	NULL
.	NULL

Axin	NULL
,	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
the	NULL
Want	NULL
signaling	NULL
pathway	NULL
,	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
GSK-3beta	NULL
and	NULL
beta-catenin	NULL
and	NULL
promotes	NULL
GSK-3beta-depen-dent	NULL
phosphorylation	NULL
of	NULL
beta-catenin	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

17:1371-1384	NULL
.	NULL

Kinzler	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
B.	NULL
Vogelstein	NULL
.	NULL

1996	NULL
.	NULL

Lessons	NULL
from	NULL
hereditary	NULL
colorectal	NULL
cancer	NULL
.	NULL

Cell	NULL
87:159-170	NULL
.	NULL

Kishida	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Yamamoto	NULL
,	NULL
S.	NULL
Ikeda	NULL
,	NULL
M.	NULL
Kishida	NULL
,	NULL
I.	NULL
Sakamoto	NULL
,	NULL
S.	NULL
Koyama	NULL
,	NULL
and	NULL
A.	NULL
Kikuchi	NULL
.	NULL

1998	NULL
.	NULL

Axin	NULL
,	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
the	NULL
wnt	NULL
signaling	NULL
pathway	NULL
,	NULL
directly	NULL
interacts	NULL
with	NULL
adenomatous	NULL
polyposis	NULL
coli	NULL
and	NULL
regulates	NULL
the	NULL
stabilization	NULL
of	NULL
beta-catenin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:10823-10826	NULL
.	NULL

Klingensmith	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Nusse	NULL
,	NULL
and	NULL
N.	NULL
Perrimon	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
Drosophila	NULL
segment	NULL
polarity	NULL
gene	NULL
dishevelled	NULL
encodes	NULL
a	NULL
novel	NULL
protein	NULL
required	NULL
for	NULL
response	NULL
to	NULL
the	NULL
wingless	NULL
signal	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:118-130	NULL
.	NULL

Korinek	NULL
,	NULL
V.	NULL
,	NULL
N.	NULL
Barker	NULL
,	NULL
P.	NULL
Morin	NULL
,	NULL
D.	NULL
van	NULL
Wichen	NULL
,	NULL
R.	NULL
de	NULL
Weger	NULL
,	NULL
K.	NULL
Kinzler	NULL
,	NULL
B.	NULL
Vogelstein	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1997	NULL
.	NULL

Constitutive	NULL
transcriptional	NULL
activation	NULL
by	NULL
a	NULL
beta-catenin-Tcf	NULL
complex	NULL
in	NULL
APC-/-	NULL
colon	NULL
carcinoma	NULL
.	NULL

Science	NULL
275:1784-1787	NULL
.	NULL

Korinek	NULL
,	NULL
V.	NULL
,	NULL
N.	NULL
Barker	NULL
,	NULL
K.	NULL
Willert	NULL
,	NULL
M.	NULL
Molenaar	NULL
,	NULL
J.	NULL
Roose	NULL
,	NULL
G.	NULL
Wagenaar	NULL
,	NULL
M.	NULL
Markman	NULL
,	NULL
W.	NULL
Lamers	NULL
,	NULL
O.	NULL
Destree	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1998	NULL
.	NULL

Two	NULL
members	NULL
of	NULL
the	NULL
Tef	NULL
family	NULL
implicated	NULL
in	NULL
Wnt/B-catenin	NULL
signaling	NULL
during	NULL
embryogenesis	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:1248-1256	NULL
.	NULL

Levanon	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
E.	NULL
Goldstein	NULL
,	NULL
Y.	NULL
Bernstein	NULL
,	NULL
H.	NULL
Tang	NULL
,	NULL
D.	NULL
Goldenberg	NULL
,	NULL
S.	NULL
Stifani	NULL
,	NULL
Z.	NULL
Paroush	NULL
,	NULL
and	NULL
Y.	NULL
Groner	NULL
.	NULL

1998	NULL
.	NULL

Transcriptional	NULL
repression	NULL
by	NULL
AML1	NULL
and	NULL
LEF-1	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
TLE/Groucho	NULL
corepressors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:11590-11595	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
S.	NULL
,	NULL
I.	NULL
Ha	NULL
,	NULL
E.	NULL
Maldonado	NULL
,	NULL
D.	NULL
Reinberg	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1991	NULL
.	NULL

Binding	NULL
of	NULL
general	NULL
transcription	NULL
factor	NULL
TFIIB	NULL
to	NULL
an	NULL
acidic	NULL
activating	NULL
region	NULL
.	NULL

Nature	NULL
353:569-571	NULL
.	NULL

Love	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

Case	NULL
,	NULL
K.	NULL
Giese	NULL
,	NULL
R.	NULL
Grosschedl	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Wright	NULL
.	NULL

1995	NULL
.	NULL

Structural	NULL
basis	NULL
for	NULL
DNA	NULL
bending	NULL
by	NULL
the	NULL
architectural	NULL
transcription	NULL
factor	NULL
LEF-1	NULL
.	NULL

Nature	NULL
376:791-795	NULL
.	NULL

Malik	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Eickbush	NULL
,	NULL
and	NULL
D.	NULL
Goldfarb	NULL
.	NULL

1997	NULL
.	NULL

Evolutionary	NULL
specialization	NULL
of	NULL
the	NULL
nuclear	NULL
targeting	NULL
apparatus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:13738-13742	NULL
.	NULL

Mangalam	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
V.	NULL
R.	NULL
Albert	NULL
,	NULL
H.	NULL
A.	NULL
Ingraham	NULL
,	NULL
M.	NULL
Kapiloff	NULL
,	NULL
L.	NULL
Wilson	NULL
,	NULL
C.	NULL
Nelson	NULL
,	NULL
H.	NULL
Elsholtz	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
pituitary	NULL
POU	NULL
domain	NULL
protein	NULL
,	NULL
Pit-1	NULL
,	NULL
activates	NULL
both	NULL
growth	NULL
hormone	NULL
and	NULL
prolactin	NULL
promoters	NULL
tran-scriptionally	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:946-958	NULL
.	NULL

Miller	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
Moon	NULL
.	NULL

1996	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
beta-catenin	NULL
and	NULL
specification	NULL
of	NULL
cell	NULL
fate	NULL
during	NULL
embryogenesis	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2527-2539	NULL
.	NULL

Molenaar	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
J.	NULL
Peterson-Maduro	NULL
,	NULL
S.	NULL
Godsave	NULL
,	NULL
V.	NULL
Korinek	NULL
,	NULL
J.	NULL
Roose	NULL
,	NULL
O.	NULL
Destree	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1996	NULL
.	NULL

XTCF-3	NULL
transcription	NULL
factor	NULL
mediates	NULL
B-catenin-induced	NULL
axis	NULL
formation	NULL
in	NULL
Xenopus	NULL
embryos	NULL
.	NULL

Cell	NULL
86:391-399	NULL
.	NULL

Morin	NULL
,	NULL
P.	NULL
,	NULL
A.	NULL
Sparks	NULL
,	NULL
V.	NULL
Korinek	NULL
,	NULL
N.	NULL
Barker	NULL
,	NULL
H.	NULL
Clevers	NULL
,	NULL
B.	NULL
Vogelstein	NULL
,	NULL
and	NULL
K.	NULL
Kinzler	NULL
.	NULL

1997	NULL
.	NULL

Activation	NULL
of	NULL
beta-catenin-Tef	NULL
signaling	NULL
in	NULL
colon	NULL
cancer	NULL
by	NULL
mutations	NULL
in	NULL
beta-catenin	NULL
or	NULL
APC	NULL
.	NULL

Science	NULL
275:1787-1790	NULL
.	NULL

Munemitsu	NULL
,	NULL
S.	NULL
,	NULL
I.	NULL
Albert	NULL
,	NULL
B.	NULL
Rubinfeld	NULL
,	NULL
and	NULL
P.	NULL
Polakis	NULL
.	NULL

1996	NULL
.	NULL

Deletion	NULL
of	NULL
an	NULL
amino-terminal	NULL
sequence	NULL
stabilizes	NULL
B-catenin	NULL
in	NULL
vivo	NULL
and	NULL
promotes	NULL
hyper-phosphorylation	NULL
of	NULL
the	NULL
adenomatous	NULL
polyposis	NULL
coli	NULL
tumor	NULL
suppressor	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:4088-4094	NULL
.	NULL

46a	NULL
.	NULL

Munguia	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Waterman	NULL
.	NULL

Unpublished	NULL
results	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

Nigg	NULL
,	NULL
E.	NULL
1997	NULL
.	NULL

Nucleocytoplasmic	NULL
transport	NULL
:	NULL
signals	NULL
,	NULL
mechanisms	NULL
and	NULL
regu-lation	NULL
.	NULL

Nature	NULL
386:779-787	NULL
.	NULL

Orsulic	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Peifer	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
in	NULL
vivo	NULL
structure-function	NULL
study	NULL
of	NULL
armadillo	NULL
,	NULL
the	NULL
B-catenin	NULL
homologue	NULL
,	NULL
reveals	NULL
both	NULL
separate	NULL
and	NULL
overlapping	NULL
regions	NULL
of	NULL
the	NULL
protein	NULL
required	NULL
for	NULL
cell	NULL
adhesion	NULL
and	NULL
for	NULL
wingless	NULL
signaling	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

134:1283-1300	NULL
.	NULL

NUCLEAR	NULL
LOCALIZATION	NULL
AND	NULL
GENE	NULL
ACTIVATION	NULL
BY	NULL
B-CATENIN	NULL
49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

4515	NULL
Papkoff	NULL
,	NULL
J.	NULL
,	NULL
B.	NULL
Rubinfeld	NULL
,	NULL
B.	NULL
Schryver	NULL
,	NULL
and	NULL
P.	NULL
Polakis	NULL
.	NULL

1996	NULL
.	NULL

Wnt-1	NULL
regulates	NULL
free	NULL
pools	NULL
of	NULL
catenins	NULL
and	NULL
stabilizes	NULL
APC-catenin	NULL
complexes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:2128-2134	NULL
.	NULL

Peifer	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Berg	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Reynolds	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
repeating	NULL
amino	NULL
acid	NULL
motif	NULL
shared	NULL
by	NULL
proteins	NULL
with	NULL
diverse	NULL
cellular	NULL
roles	NULL
.	NULL

Cell	NULL
76:789-791	NULL
.	NULL

Pinol-Roma	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
G.	NULL
Dreyfuss	NULL
.	NULL

1992	NULL
.	NULL

Shuttling	NULL
of	NULL
pre-mRNA	NULL
binding	NULL
proteins	NULL
between	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

Nature	NULL
355:730-732	NULL
.	NULL

Polakis	NULL
,	NULL
P.	NULL
1997	NULL
.	NULL

The	NULL
adenomatous	NULL
polyposis	NULL
coli	NULL
(	NULL
APC	NULL
)	NULL
tumor	NULL
suppressor	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1332	NULL
:	NULL
F127-F147	NULL
.	NULL

Porfiri	NULL
,	NULL
E.	NULL
,	NULL
B.	NULL
Rubinfeld	NULL
,	NULL
I.	NULL
Albert	NULL
,	NULL
K.	NULL
Hovanes	NULL
,	NULL
M.	NULL
Waterman	NULL
,	NULL
and	NULL
P.	NULL
Polakis	NULL
.	NULL

1998	NULL
.	NULL

Induction	NULL
of	NULL
a	NULL
beta-catenin-LEF-1	NULL
complex	NULL
by	NULL
Wat-1	NULL
and	NULL
transforming	NULL
mutants	NULL
of	NULL
beta-catenin	NULL
.	NULL

Oncogene	NULL
15:2833-2839	NULL
.	NULL

53a.Prieve	NULL
,	NULL
M.	NULL
G.	NULL
Unpublished	NULL
results	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

Prieve	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
L.	NULL
Guttridge	NULL
,	NULL
J.	NULL
E.	NULL
Munguia	NULL
,	NULL
and	NULL
M.	NULL
Waterman	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor-1	NULL
is	NULL
recognized	NULL
by	NULL
two	NULL
differentially	NULL
expressed	NULL
Srp1-NLS	NULL
receptor	NULL
proteins	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
7654-7658	NULL
.	NULL

Prieve	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
K.	NULL
L.	NULL
Guttridge	NULL
,	NULL
J.	NULL
Munguia	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Waterman	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
importin	NULL
«	NULL
recognition	NULL
and	NULL
nuclear	NULL
transport	NULL
by	NULL
nuclear	NULL
localization	NULL
signals	NULL
within	NULL
the	NULL
high-mobility-group	NULL
DNA	NULL
binding	NULL
domains	NULL
of	NULL
lymphoid	NULL
enhancer	NULL
factor	NULL
1	NULL
and	NULL
T-cell	NULL
factor	NULL
1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:4819-4832	NULL
.	NULL

55a.Prieve	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Waterman	NULL
.	NULL

Unpublished	NULL
results	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

Roose	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Molenaar	NULL
,	NULL
J.	NULL
Peterson	NULL
,	NULL
J.	NULL
Hurenkamp	NULL
,	NULL
H.	NULL
Brantjes	NULL
,	NULL
P.	NULL
Moerer	NULL
,	NULL
M.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
O.	NULL
Destree	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Xenopus	NULL
Wat	NULL
effector	NULL
XTef-3	NULL
interacts	NULL
with	NULL
Groucho-related	NULL
transcriptional	NULL
repressors	NULL
.	NULL

Nature	NULL
395:608-612	NULL
.	NULL

Rubinfeld	NULL
,	NULL
B.	NULL
,	NULL
I.	NULL
Albert	NULL
,	NULL
E.	NULL
Porfiri	NULL
,	NULL
C.	NULL
Fiol	NULL
,	NULL
S.	NULL
Munemitsu	NULL
,	NULL
and	NULL
P.	NULL
Polakis	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
of	NULL
GSK38	NULL
to	NULL
the	NULL
APC-beta-catenin	NULL
complex	NULL
and	NULL
regulation	NULL
of	NULL
complex	NULL
assembly	NULL
.	NULL

Science	NULL
272:1023-1026	NULL
.	NULL

Rubinfeld	NULL
,	NULL
B.	NULL
,	NULL
B.	NULL
Souza	NULL
,	NULL
I.	NULL
Albert	NULL
,	NULL
S.	NULL
Munemitsu	NULL
,	NULL
and	NULL
P.	NULL
Polakis	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
APC	NULL
protein	NULL
and	NULL
E-cadherin	NULL
form	NULL
similar	NULL
but	NULL
independent	NULL
complexes	NULL
with	NULL
alpha-catenin	NULL
,	NULL
beta-catenin	NULL
,	NULL
and	NULL
plakoglobin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:5549-5555	NULL
.	NULL

Simcha	NULL
,	NULL
I.	NULL
,	NULL
M.	NULL
Shtutman	NULL
,	NULL
D.	NULL
Salomon	NULL
,	NULL
J.	NULL
Zhurinsky	NULL
,	NULL
E.	NULL
Sadot	NULL
,	NULL
B.	NULL
Geiger	NULL
,	NULL
and	NULL
A.	NULL
Ben-Ze'ev	NULL
.	NULL

1998	NULL
.	NULL

Differential	NULL
nuclear	NULL
translocation	NULL
and	NULL
transactivation	NULL
potential	NULL
of	NULL
beta-catenin	NULL
and	NULL
plakoglobin	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

141:1433-1448	NULL
.	NULL

Swain	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
Croft	NULL
,	NULL
C.	NULL
Dubey	NULL
,	NULL
L.	NULL
Haynes	NULL
,	NULL
P.	NULL
Rogers	NULL
,	NULL
X.	NULL
Zhang	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Bradley	NULL
.	NULL

1996	NULL
.	NULL

From	NULL
naive	NULL
to	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

150:143-167	NULL
.	NULL

Theisen	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Purcell	NULL
,	NULL
M.	NULL
Bennett	NULL
,	NULL
D.	NULL
Kansagara	NULL
,	NULL
A.	NULL
Syed	NULL
,	NULL
and	NULL
J.	NULL
Marsh	NULL
.	NULL

1994	NULL
.	NULL

Dishevelled	NULL
is	NULL
required	NULL
during	NULL
wingless	NULL
signaling	NULL
to	NULL
establish	NULL
both	NULL
cell	NULL
polarity	NULL
and	NULL
cell	NULL
identity	NULL
.	NULL

Development	NULL
120:347-360	NULL
.	NULL

Travis	NULL
,	NULL
A.	NULL
,	NULL
A.	NULL
Amsterdam	NULL
,	NULL
C.	NULL
Belanger	NULL
,	NULL
and	NULL
R.	NULL
Grosschedl	NULL
.	NULL

1991	NULL
.	NULL

LEF-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
lymphoid-specific	NULL
protein	NULL
with	NULL
an	NULL
HMG	NULL
domain	NULL
,	NULL
regulates	NULL
T-cell	NULL
receptor	NULL
alpha	NULL
enhancer	NULL
function	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:880-894.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
Cavallo	NULL
,	NULL
D.	NULL
Dooijes	NULL
,	NULL
M.	NULL
van	NULL
Beest	NULL
,	NULL
J.	NULL
van	NULL
Es	NULL
,	NULL
J.	NULL
Loureiro	NULL
,	NULL
A.	NULL
Ypma	NULL
,	NULL
D.	NULL
Hursh	NULL
,	NULL
T.	NULL
Jones	NULL
,	NULL
A.	NULL
Bejsovec	NULL
,	NULL
M.	NULL
Peifer	NULL
,	NULL
M.	NULL
Mortin	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1997	NULL
.	NULL

Armadillo	NULL
coactivates	NULL
transcription	NULL
driven	NULL
by	NULL
the	NULL
product	NULL
of	NULL
the	NULL
Drosophila	NULL
segment	NULL
polarity	NULL
gene	NULL
dTCF	NULL
.	NULL

Cell	NULL
88:789-799.	NULL
van	NULL
de	NULL
Wetering	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Oosterwegel	NULL
,	NULL
D.	NULL
Dooijes	NULL
,	NULL
and	NULL
H.	NULL
Clevers	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
and	NULL
cloning	NULL
of	NULL
TCF-1	NULL
,	NULL
a	NULL
T	NULL
lymphocyte	NULL
specific	NULL
transcription	NULL
factor	NULL
containing	NULL
a	NULL
sequence-specific	NULL
HMG	NULL
box	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:123-132	NULL
.	NULL

Waltzer	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Bienz	NULL
.	NULL

1998	NULL
.	NULL

Drosophila	NULL
CBP	NULL
represses	NULL
the	NULL
transcription	NULL
factor	NULL
TCF	NULL
to	NULL
antagonize	NULL
Wingless	NULL
signalling	NULL
.	NULL

Nature	NULL
395:521-525	NULL
.	NULL

Waterman	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
W.	NULL
H.	NULL
Fischer	NULL
,	NULL
and	NULL
K.	NULL
A.	NULL
Jones	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
thymus-specific	NULL
member	NULL
of	NULL
the	NULL
HMG	NULL
protein	NULL
family	NULL
regulates	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
C	NULL
alpha	NULL
enhancer	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

5:656-669	NULL
.	NULL

Welsh	NULL
,	NULL
G.	NULL
I.	NULL
,	NULL
S.	NULL
Miyamoto	NULL
,	NULL
N.	NULL
T.	NULL
Price	NULL
,	NULL
B	NULL
.	NULL

Safer	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Proud	NULL
.	NULL

1996	NULL
.	NULL

T-cell	NULL
activation	NULL
leads	NULL
to	NULL
rapid	NULL
stimulation	NULL
of	NULL
translation	NULL
initiation	NULL
factor	NULL
eIF2B	NULL
and	NULL
inactivation	NULL
of	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:11410-11413	NULL
.	NULL

Woodgett	NULL
,	NULL
J	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
and	NULL
functions	NULL
of	NULL
the	NULL
glycogen	NULL
synthase	NULL
kinase-3	NULL
subfamily	NULL
.	NULL

Semin	NULL
.	NULL

Cancer	NULL
Biol	NULL
.	NULL

5:269-275	NULL
.	NULL

Yamamoto	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Kishida	NULL
,	NULL
T.	NULL
Uochi	NULL
,	NULL
S.	NULL
Ikeda	NULL
,	NULL
S.	NULL
Koyama	NULL
,	NULL
M.	NULL
Asashima	NULL
,	NULL
and	NULL
A.	NULL
Kikuchi	NULL
.	NULL

1998	NULL
.	NULL

Axil	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Axin	NULL
family	NULL
,	NULL
interacts	NULL
with	NULL
both	NULL
glycogen	NULL
synthase	NULL
kinase	NULL
3B	NULL
and	NULL
B-catenin	NULL
and	NULL
inhibits	NULL
axis	NULL
formation	NULL
of	NULL
Xenopus	NULL
embryos	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18:2867-2875	NULL
.	NULL

Yost	NULL
,	NULL
C.	NULL
,	NULL
H.	NULL
F.	NULL
Gist	NULL
III	NULL
,	NULL
S.	NULL
B	NULL
.	NULL

Pierce	NULL
,	NULL
D.	NULL
M.	NULL
Ferkey	NULL
,	NULL
M.	NULL
M.	NULL
Chen	NULL
,	NULL
and	NULL
D.	NULL
Kimelman	NULL
.	NULL

1998	NULL
.	NULL

GBP	NULL
,	NULL
and	NULL
inhibitor	NULL
of	NULL
GSK-3	NULL
,	NULL
is	NULL
implicated	NULL
in	NULL
Xenopus	NULL
development	NULL
and	NULL
oncogenesis	NULL
.	NULL

Cell	NULL
93:1031-1041	NULL
.	NULL

Yu	NULL
,	NULL
G.	NULL
,	NULL
F.	NULL
Chen	NULL
,	NULL
G.	NULL
Levesque	NULL
,	NULL
M.	NULL
Nishimura	NULL
,	NULL
D.-M.	NULL
Zhang	NULL
,	NULL
L.	NULL
Levesque	NULL
,	NULL
E.	NULL
Rogaeva	NULL
,	NULL
D.	NULL
Xu	NULL
,	NULL
Y.	NULL
Lian	NULL
,	NULL
M.	NULL
Duthei	NULL
,	NULL
P.	NULL
St.	NULL
George-Hyslop	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Fraser	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
presenilin	NULL
1	NULL
protein	NULL
is	NULL
a	NULL
component	NULL
of	NULL
a	NULL
high	NULL
molecular	NULL
weight	NULL
intracellular	NULL
complex	NULL
that	NULL
contains	NULL
B-catenin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:16470-16475	NULL
.	NULL

Zeng	NULL
,	NULL
L.	NULL
,	NULL
F.	NULL
Fagotto	NULL
,	NULL
T.	NULL
Zhang	NULL
,	NULL
W.	NULL
Hsu	NULL
,	NULL
T.	NULL
J.	NULL
Vasicek	NULL
,	NULL
W.	NULL
L.	NULL
Perry	NULL
,	NULL
J.	NULL
J.	NULL
Lee	NULL
,	NULL
S.	NULL
M.	NULL
Tilghman	NULL
,	NULL
B.	NULL
M.	NULL
Gumbiner	NULL
,	NULL
and	NULL
F.	NULL
Costantini	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
mouse	NULL
fused	NULL
locus	NULL
encodes	NULL
Axin	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
Wat	NULL
signaling	NULL
pathway	NULL
that	NULL
regulates	NULL
embryonic	NULL
axis	NULL
formation	NULL
.	NULL

Cell	NULL
90:181-192	NULL
.	NULL

